Annotation Detail for CCL2
Basic Information Top
| Gene Symbol: | CCL2 ( GDCF-2,HC11,HSMCR30,MCAF,MCP-1,MCP1,MGC9434,SCYA2,SMC-CF ) |
|---|---|
| Gene Full Name: | chemokine (C-C motif) ligand 2 |
| Band: | 17q12 |
| Quick Links | Entrez ID:6347; OMIM: 158105; Uniprot ID:CCL2_HUMAN; ENSEMBL ID: ENSG00000108691; HGNC ID: 10618 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa05142 | Chagas disease |
| hsa05144 | Malaria |
| hsa04621 | NOD-like receptor signaling pathway |
| hsa04062 | Chemokine signaling pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| Pathway ID | Pathway Name |
|---|---|
| Signaling by GPCR | |
| Diabetes pathways |
| Pathway ID | Pathway Name |
|---|---|
| 200131 | IL23-mediated signaling events |
| 200015 | GMCSF-mediated signaling events |
| 200118 | AP-1 transcription factor network |
| 200044 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| Pathway ID | Pathway Name |
|---|---|
| P00031 | Inflammation mediated by chemokine and cytokine signaling pathway |
| No data |
| No data |
| Desease ID | Desease Name |
|---|---|
| 1731 | Growth retardation |
| 1740 | Alzheimer's disease |
| 1770 | Melanoma |
| 1777 | Intractable epilepsy |
| 1798 | Lyme disease |
| 1800 | Lupus vulgaris |
| 1807 | Autoimmune disease |
| 1809 | HIV infection |
| 1818 | Systemic scleroderma |
| 1831 | Prostate cancer |
| 1840 | Macular degeneration |
| 1856 | Obesity |
| 1860 | Brain tumor |
| 1861 | Epstein-Barr virus infection |
| 1889 | Hyperinsulinism |
| 1901 | Endometriosis |
| 1902 | Kidney failure |
| 1904 | Diabetes mellitus |
| 1907 | Depression |
| 1918 | Atherosclerosis |
| 1932 | Pancreatitis |
| 2002 | Hemorrhagic fevers, Viral |
| 1936 | Hypercholesterolemia |
| 1976 | Squamous cell cancer |
| 1983 | Down syndrome |
| 1993 | Esophagus cancer |
| 1841 | Stomach cancer |
| 2008 | Liver disease |
| 2022 | Liver cancer |
| 2028 | Nasopharyngeal cancer |
| 2029 | Tuberculosis |
| 2030 | Bronchiolitis |
| 2045 | Bipolar disorder |
| 2050 | Peptic esophagitis |
| 2051 | Leukemia |
| 2069 | Schizophrenia |
| 2075 | Heart failure |
| 2081 | Pulmonary fibrosis |
| 2083 | IGA glomerulonephritis |
| 2039 | Hyperhomocysteinemia |
| 2099 | Hepatitis B |
| 2100 | Hepatitis C |
| 2107 | Proteinuria |
| 2108 | Nephritis |
| 2128 | CNS metastases |
| 2134 | Amyotrophic lateral sclerosis |
| 2136 | Hypothyroidism |
| 2151 | Neuroblastoma |
| 2166 | Influenza |
| 1912 | Penile disease |
| 1796 | Labor, Premature |
| 2176 | Tuberous sclerosis |
| 2230 | Alopecia |
| 2231 | Arthritis |
| 1846 | Pleural effusion, Malignant |
| 2238 | Lipodystrophy |
| 1805 | Mycobacterium infection, Atypical |
| 2241 | Infertility |
| Desease Name |
|---|
| Chagas Disease |
| tuberculosis |
| CARDIOVASCULAR |
| Coronary Artery Disease |
| myocardial infarct |
| atherosclerosis, carotid |
| pancreatitis, chronic |
| Asthma. asthma severity |
| Hepatitis B, Chronic |
| PHARMACOGENOMIC |
| bone density |
| Asthma |
| nephropathy in other diseases |
| Edema rosiglitazone or pioglitazone |
| sclerosis, systemic |
| systemic lupus erythematosus |
| IMMUNE |
| NEUROLOGICAL |
| glucose insulin |
| METABOLIC |
| Crohn's disease |
| HIV |
| diabetes, type 2 |
| Hepatitis C, Chronic |
| Dementia |
| renal tubular damage |
| INFECTION |
| diabetes, type 2 metabolic syndrome |
| intima-media thickness |
| carpal-tunnel syndrome |
| No data |
| Desease Name |
|---|
| Mycobacterium tuberculosis, susceptibility to |
| HIV-1, resistance to |
| Coronary artery disease, modifier of |
| Spina bifida, susceptibility to |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester results in decreased expression of CCL2 mRNA | decreases expression | 11340305 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11961005 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14576080 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [Superoxides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 8856246 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea results in decreased expression of CCL2 mRNA | decreases expression | 11128050 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [oil fly ash results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14569496 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | affects binding|decreases expression|decreases reaction | 15187150 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | affects binding|decreases expression|decreases reaction | 15187150 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15531761 |
| C477819 | 15-deoxyprostaglandin J2 | fluticasone promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 15531761 |
| C477819 | 15-deoxyprostaglandin J2 | salmeterol promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 15531761 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CCL2 mRNA | decreases expression | 19933214 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 15698426 |
| C003585 | 22-hydroxycholesterol | 22-hydroxycholesterol results in increased expression of CCL2 mRNA | increases expression | 19426978 |
| C010422 | 2,4,6-trichlorophenyl 4-nitrophenyl ether | 2,4,6-trichlorophenyl 4-nitrophenyl ether results in increased expression of CCL2 mRNA | increases expression | 15110079 |
| C010422 | 2,4,6-trichlorophenyl 4-nitrophenyl ether | 2,4,6-trichlorophenyl 4-nitrophenyl ether results in increased expression of CCL2 protein | increases expression | 15110079 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of CCL2 mRNA | increases expression | 20713471 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16794257 |
| C094503 | 2-arachidonylglycerol | 2-arachidonylglycerol results in increased expression of CCL2 protein | increases expression | 15115777 |
| C113043 | 2-methylthio-ADP | 2-methylthio-ADP results in increased secretion of CCL2 protein | increases secretion | 16856976 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of CCL2 mRNA | affects binding|increases activity|increases expression | 10821843 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA | increases expression | 10218491 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein | increases expression | 10218491 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10218491 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein] | increases expression|increases reaction | 10218491 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 10218491 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17666914 |
| C031285 | 3-xylene | 3-xylene results in increased expression of CCL2 protein | increases expression | 17993253 |
| C031285 | 3-xylene | 3-xylene results in increased expression of CCL2 protein | increases expression | 15902427 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15721863 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of CCL2 mRNA | increases expression | 18648102 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18645721 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide affects the expression of CCL2 mRNA | affects expression | 17766677 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | ALOX5 protein affects the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide affects the expression of CCL2 mRNA] | affects expression|affects reaction | 17766677 |
| C081510 | 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone | 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein | decreases expression | 15762874 |
| C025566 | 4-methylhistamine | 4-methylhistamine results in decreased expression of CCL2 protein | decreases expression | 17507084 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein | decreases expression | 15762874 |
| C056369 | 5-(N-methyl-N-isobutyl)amiloride | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| D020909 | Acarbose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17133782 |
| D020909 | Acarbose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17133782 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased expression of CCL2 mRNA | increases expression | 17050345 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CCL2 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 mRNA | increases expression | 14557383 19799668 12153990 15578514 14550746 16552707 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 protein | increases expression | 19799668 11981759 14557383 16081117 |
| D000082 | Acetaminophen | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19799668 |
| D000082 | Acetaminophen | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19799668 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 15578514 |
| D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 14557383 14550746 |
| D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 protein] | increases expression|increases reaction | 14557383 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 protein | increases expression | 16687475 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16845898 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15139008 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 10541287 |
| D000171 | Acrolein | Acrolein results in increased expression of CCL2 mRNA | increases expression | 17982132 |
| D000171 | Acrolein | Acrolein results in increased expression of CCL2 mRNA | increases expression | 17950725 |
| D000171 | Acrolein | CD8A protein promotes the reaction [Acrolein results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17950725 |
| D000181 | Acrylonitrile | Acrylonitrile results in decreased expression of CCL2 mRNA | decreases expression | 16173056 |
| D000493 | Allopurinol | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | affects cotreatment|decreases reaction|increases secretion | 19158351 |
| D000493 | Allopurinol | Allopurinol inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17666914 |
| D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16317058 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19735175 |
| D000584 | Amiloride | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| D000584 | Amiloride | Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D000584 | Amiloride | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D000584 | Amiloride | Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D000584 | Amiloride | Amiloride results in decreased expression of CCL2 mRNA | decreases expression | 11340305 |
| D000584 | Amiloride | Amiloride results in decreased expression of CCL2 protein | decreases expression | 11340305 |
| D000584 | Amiloride | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 11340305 |
| D000584 | Amiloride | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein] | decreases expression|decreases reaction | 11340305 |
| D006710 | Homocysteine | acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16845898 |
| D006710 | Homocysteine | Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16845898 |
| D006710 | Homocysteine | Homocysteine results in increased expression of CCL2 mRNA | increases expression | 16845898 11356643 |
| D006710 | Homocysteine | Homocysteine results in increased expression of CCL2 protein | increases expression | 11356643 |
| D006710 | Homocysteine | [Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein | increases expression|increases phosphorylation | 11356643 |
| D006710 | Homocysteine | [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA | increases expression|increases reduction | 11356643 |
| D000638 | Amiodarone | Amiodarone inhibits the reaction [CRP protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19225199 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CCL2 mRNA | affects expression | 16483693 |
| C095108 | amprenavir | amprenavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17460151 |
| D000967 | Antimony Sodium Gluconate | Antimony Sodium Gluconate results in decreased expression of CCL2 mRNA | decreases expression | 20102417 |
| D001151 | Arsenic | Arsenic results in increased expression of CCL2 mRNA | increases expression | 12928151 |
| D001151 | Arsenic | CCL2 polymorphism results in increased susceptibility to Arsenic | increases response to substance | 18022660 |
| C058317 | arsenic disulfide | arsenic disulfide results in increased expression of CCL2 mRNA | increases expression | 16918137 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 19828696 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 protein | affects cotreatment|increases expression | 19828696 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 mRNA | increases expression | 19828696 18231732 15761015 20458559 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 protein | increases expression | 19828696 |
| C015001 | arsenite | arsenite results in decreased expression of CCL2 mRNA | decreases expression | 16085347 |
| C015001 | arsenite | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 16085347 |
| D001194 | Asbestos | Asbestos results in increased expression of CCL2 protein | increases expression | 18795166 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of CCL2 mRNA | increases expression | 10923243 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of CCL2 protein | increases expression | 10923243 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased secretion of CCL2 protein | increases secretion | 10923243 |
| D017638 | Asbestos, Crocidolite | IL1B protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10923243 |
| D017638 | Asbestos, Crocidolite | IL1B protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of CCL2 protein] | increases reaction|increases secretion | 10923243 |
| D017638 | Asbestos, Crocidolite | TNF protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10923243 |
| D017638 | Asbestos, Crocidolite | TNF protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of CCL2 protein] | increases reaction|increases secretion | 10923243 |
| D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| C528574 | astressin-2B | astressin-2B inhibits the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16920976 |
| C413408 | atazanavir | atazanavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16705055 |
| D001554 | Benzene | Benzene results in increased expression of CCL2 protein | increases expression | 15902427 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 21295105 |
| D019324 | beta-Naphthoflavone | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CCL2 mRNA | decreases expression | 20064835 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CCL2 mRNA | increases expression | 20713471 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CCL2 mRNA | affects expression | 20382639 |
| C004532 | benzoquinone | benzoquinone results in increased expression of CCL2 protein | increases expression | 17572062 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11698246 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11698246 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 10541287 |
| D001599 | Berberine | Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16391493 |
| D001599 | Berberine | Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16391493 |
| D001599 | Berberine | Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16391493 |
| D001599 | Berberine | Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16391493 |
| D047071 | beta-Glucans | beta-Glucans results in increased expression of CCL2 protein | increases expression | 17572156 |
| C013185 | beta-penta-O-galloyl-glucose | beta-penta-O-galloyl-glucose inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16253226 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 16317058 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 16317058 |
| C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of CCL2 mRNA | increases expression | 15912405 |
| C006780 | bisphenol A | bisphenol A affects the expression of CCL2 mRNA | affects expression | 19490990 |
| D001761 | Bleomycin | Bleomycin results in increased expression of CCL2 mRNA | increases expression | 15541506 16314464 17177178 |
| D001761 | Bleomycin | Bleomycin results in increased expression of CCL2 protein | increases expression | 15541506 |
| D001761 | Bleomycin | CCL11 protein promotes the reaction [Bleomycin results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 16314464 |
| D001761 | Bleomycin | CEBPB protein affects the reaction [Bleomycin results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 17177178 |
| D001761 | Bleomycin | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15541506 |
| D001761 | Bleomycin | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15541506 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 11230753 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 11230753 |
| D019819 | Budesonide | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15734790 |
| D019819 | Budesonide | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15734790 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased expression of CCL2 protein | increases expression | 16443645 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased secretion of CCL2 protein | increases secretion | 16443645 |
| D020148 | Butyric Acid | Butyric Acid results in increased expression of CCL2 mRNA | increases expression | 17928716 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 16085347 |
| D000001 | Calcimycin | Calcimycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D000001 | Calcimycin | Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18799549 |
| D002118 | Calcium | CCL2 protein results in increased abundance of Calcium | increases abundance | 16771778 |
| D002118 | Calcium | CCL2 protein results in increased uptake of Calcium | increases uptake | 10984371 |
| D002118 | Calcium | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | decreases reaction|increases abundance | 16771778 |
| D002118 | Calcium | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | decreases reaction|increases uptake | 10843593 |
| D002118 | Calcium | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | affects localization|decreases reaction | 16212921 |
| C058819 | calphostin C | calphostin C inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11961005 |
| C073718 | cannabidiol hydroxyquinone | cannabidiol hydroxyquinone results in decreased expression of CCL2 mRNA | decreases expression | 16571653 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of CCL2 mRNA | decreases expression | 17719033 |
| D002211 | Capsaicin | Capsaicin results in decreased secretion of CCL2 protein | decreases secretion | 17719033 |
| D002211 | Capsaicin | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | decreases secretion|increases reaction | 17719033 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CCL2 mRNA | increases expression | 17125873 12500195 |
| D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA] | decreases reaction|increases expression | 17125873 |
| D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] | decreases reaction|increases expression | 17125873 |
| D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] | decreases reaction|increases expression | 17125873 |
| D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA] | decreases reaction|increases expression | 17125873 |
| D002251 | Carbon Tetrachloride | FOXF1A protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 12500195 |
| D002330 | Carmustine | Carmustine results in increased expression of CCL2 mRNA | increases expression | 15980968 |
| D002336 | Carnosine | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19799668 |
| D002336 | Carnosine | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19799668 |
| D002351 | Carrageenan | Carrageenan results in increased expression of CCL2 protein | increases expression | 12444156 |
| D002392 | Catechin | Catechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17103373 |
| C034221 | catechol | catechol results in increased expression of CCL2 protein | increases expression | 17572062 |
| C105934 | celecoxib | celecoxib results in decreased expression of CCL2 mRNA | decreases expression | 12902868 |
| C031294 | chlorobenzene | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18645721 |
| C031294 | chlorobenzene | CCL2 protein promotes the reaction [chlorobenzene results in increased expression of IL13 protein] | increases expression|increases reaction | 18514500 |
| C031294 | chlorobenzene | chlorobenzene results in increased expression of CCL2 protein | increases expression | 17993253 18645721 18514500 |
| C031294 | chlorobenzene | SB 203580 inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18645721 |
| D002738 | Chloroquine | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15139008 |
| D002738 | Chloroquine | Chloroquine results in increased expression of CCL2 mRNA | increases expression | 15139008 |
| D002738 | Chloroquine | diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15139008 |
| D002794 | Choline | Choline affects the expression of CCL2 mRNA | affects expression | 17616785 |
| D002809 | Chondroitin Sulfates | Chondroitin Sulfates binds to CCL2 protein | affects binding | 16385517 |
| D002927 | Cimetidine | Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C086108 | clobenpropit | clobenpropit results in decreased expression of CCL2 protein | decreases expression | 17507084 |
| D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D003000 | Clonidine | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| D003300 | Copper | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 20302851 |
| D003300 | Copper | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | affects cotreatment|increases expression|increases reaction | 20302851 |
| D003345 | Corticosterone | Corticosterone results in decreased expression of CCL2 mRNA | decreases expression | 15755911 |
| C089698 | CP 105696 | CP 105696 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19880577 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17666914 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17666914 |
| D003474 | Curcumin | Curcumin results in increased expression of CCL2 mRNA | increases expression | 17198877 |
| D003474 | Curcumin | Curcumin results in decreased expression of CCL2 mRNA | decreases expression | 18403477 |
| D003474 | Curcumin | Curcumin results in decreased expression of CCL2 protein | decreases expression | 18403477 |
| D003474 | Curcumin | Curcumin results in decreased expression of CCL2 mRNA | decreases expression | 10925121 11053056 |
| D003474 | Curcumin | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19243473 |
| D003474 | Curcumin | Curcumin results in decreased expression of CCL2 | decreases expression | 18462866 |
| D018119 | Stavudine | Stavudine results in increased expression of CCL2 protein | increases expression | 17668557 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16705055 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15531761 |
| C044919 | deferiprone | deferiprone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14576080 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 mRNA | increases expression | 15371230 15681167 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 protein | increases expression | 17090620 |
| C007262 | deoxynivalenol | Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15681167 |
| D003907 | Dexamethasone | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | affects binding|decreases expression|decreases reaction | 15187150 |
| D003907 | Dexamethasone | [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein | affects binding|decreases expression | 15187150 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19255438 |
| D003907 | Dexamethasone | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | affects binding|decreases expression|decreases reaction | 15187150 |
| D003907 | Dexamethasone | [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein | affects binding|decreases expression | 15187150 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | affects cotreatment|decreases expression | 16054899 |
| D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| C020735 | dibutyldichlorotin | dibutyldichlorotin results in increased expression of CCL2 mRNA | increases expression | 10722888 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CCL2 mRNA | increases expression | 15814532 15701814 |
| D002945 | Cisplatin | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15814532 |
| D004052 | Diethylnitrosamine | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 20302851 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 21295105 |
| D004052 | Diethylnitrosamine | [Iron co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 20302851 |
| D004052 | Diethylnitrosamine | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | affects cotreatment|increases expression|increases reaction | 20302851 |
| D004052 | Diethylnitrosamine | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CCL2 protein | increases expression | 15794588 |
| C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased expression of CCL2 mRNA | decreases expression | 16507463 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of CCL2 protein | increases expression | 17719030 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17529908 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14576080 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in decreased expression of CCL2 mRNA | decreases expression | 10925121 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of CCL2 mRNA | increases expression | 15719370 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [lopinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14576080 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15139008 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16794257 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15698426 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15698426 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of and results in increased secretion of CCL2 protein | increases expression|increases secretion | 12908082 |
| D004391 | Dust | Dust affects the expression of CCL2 protein | affects expression | 17805423 |
| D004391 | Dust | Dust results in increased expression of CCL2 mRNA | increases expression | 17805423 |
| D015118 | Eicosapentaenoic Acid | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 15698426 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15698426 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15698426 |
| D004656 | Enalapril | Enalapril results in decreased expression of CCL2 mRNA | decreases expression | 10925121 |
| D004731 | Endotoxins | Endotoxins promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 12217210 |
| D004731 | Endotoxins | Endotoxins results in increased expression of CCL2 mRNA | increases expression | 12217210 |
| D004958 | Estradiol | ESR1 protein affects the reaction [Estradiol results in decreased activity of CCL2 protein] | affects reaction|decreases activity | 17006379 |
| D004958 | Estradiol | Estradiol affects the expression of CCL2 mRNA | affects expression | 14699072 |
| D004958 | Estradiol | Estradiol results in decreased activity of CCL2 protein | decreases activity | 17006379 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in decreased activity of CCL2 protein] | decreases activity|decreases reaction | 17006379 |
| D004958 | Estradiol | Estradiol affects the expression of CCL2 mRNA | affects expression | 15598610 |
| D004958 | Estradiol | Estradiol results in decreased secretion of CCL2 protein | decreases secretion | 12538720 |
| D004966 | Estrogens, Conjugated (USP) | Estrogens, Conjugated (USP) results in decreased expression of CCL2 protein | decreases expression | 16842799 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the secretion of CCL2 protein | affects secretion | 15885639 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased secretion of CCL2 protein | decreases secretion | 12538720 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CCL2 mRNA | increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CCL2 mRNA | affects expression | 17351261 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| D015525 | Fatty Acids, Omega-3 | Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15681167 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16306350 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 15968640 |
| D011345 | Fenofibrate | Fenofibrate results in decreased expression of CCL2 mRNA | decreases expression | 18356826 |
| D011345 | Fenofibrate | Fenofibrate results in decreased expression of CCL2 protein | decreases expression | 18356826 |
| D005395 | Fish Oils | Fish Oils inhibits the reaction [Fructose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15752949 |
| C109799 | FK 706 | FK 706 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12676771 |
| C109799 | FK 706 | FK 706 inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12676771 |
| C109799 | FK 706 | FK 706 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12676771 |
| C109799 | FK 706 | FK 706 inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12676771 |
| C065382 | fluticasone | fluticasone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15531761 |
| C065382 | fluticasone | fluticasone promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 15531761 |
| D005492 | Folic Acid | Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16845898 |
| D005492 | Folic Acid | Folic Acid results in decreased expression of CCL2 protein | decreases expression | 16491109 |
| D005620 | Freund's Adjuvant | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D005632 | Fructose | acetovanillone inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | affects cotreatment|decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | Allopurinol inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | [Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein | affects cotreatment|increases secretion | 19158351 |
| D005632 | Fructose | Fructose results in increased secretion of CCL2 protein | increases secretion | 19158351 |
| D005632 | Fructose | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | KHK protein promotes the reaction [Fructose results in increased secretion of CCL2 protein] | increases reaction|increases secretion | 19158351 |
| D005632 | Fructose | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005632 | Fructose | Superoxides affects the reaction [Fructose results in increased secretion of CCL2 protein] | affects reaction|increases secretion | 19158351 |
| D005632 | Fructose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17133782 |
| D005632 | Fructose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17133782 |
| D005632 | Fructose | Fish Oils inhibits the reaction [Fructose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15752949 |
| D005632 | Fructose | Fructose results in increased expression of CCL2 mRNA | increases expression | 17133782 |
| D005632 | Fructose | Fructose results in increased expression of CCL2 protein | increases expression | 15752949 17133782 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in decreased activity of CCL2 protein] | decreases activity|decreases reaction | 17006379 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Raloxifene results in decreased activity of CCL2 protein] | decreases activity|decreases reaction | 17006379 |
| C043055 | gallium arsenide | gallium arsenide results in increased secretion of CCL2 protein | increases secretion | 14560044 |
| D019833 | Genistein | Genistein results in decreased expression of CCL2 mRNA | decreases expression | 12846738 |
| D005839 | Gentamicins | Gentamicins inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17699551 |
| D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17699551 |
| D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17442725 |
| D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | increases expression|increases reaction | 17442725 |
| D005839 | Gentamicins | Gentamicins results in increased expression of CCL2 mRNA | increases expression | 17442725 |
| D005839 | Gentamicins | Gentamicins results in increased expression of CCL2 protein | increases expression | 16401625 |
| D005839 | Gentamicins | KLK1 protein inhibits the reaction [Gentamicins results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16401625 |
| D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| D005947 | Glucose | Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 19225232 |
| D005947 | Glucose | Glucose results in increased expression of CCL2 mRNA | increases expression | 16143069 16600694 19225232 17655880 |
| D005947 | Glucose | Glucose results in increased expression of CCL2 protein | increases expression | 16600694 17655880 |
| D005947 | Glucose | Glucose results in increased secretion of CCL2 protein | increases secretion | 16600694 |
| D005947 | Glucose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17655880 |
| D005947 | Glucose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17655880 |
| D005947 | Glucose | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 17655880 |
| D005947 | Glucose | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D005947 | Glucose | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D005947 | Glucose | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D005947 | Glucose | [valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 19225232 |
| D005947 | Glucose | valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 19225232 |
| D017127 | Glycosylation End Products, Advanced | Glycosylation End Products, Advanced results in increased expression of CCL2 mRNA | increases expression | 16143069 |
| D017127 | Glycosylation End Products, Advanced | SB 203580 inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D017127 | Glycosylation End Products, Advanced | Selenium inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D006072 | Gossypol | Gossypol results in decreased expression of CCL2 mRNA | decreases expression | 19825521 |
| D006072 | Gossypol | zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] | decreases expression|increases reaction | 19825521 |
| D006221 | Halothane | Halothane results in decreased expression of CCL2 mRNA | decreases expression | 15564938 |
| D006246 | Harmaline | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| D006493 | Heparin | Heparin results in decreased expression of CCL2 protein | decreases expression | 11053056 |
| D007975 | Leukotriene B4 | CCL2 protein results in increased abundance of Leukotriene B4 | increases abundance | 12388339 |
| D007975 | Leukotriene B4 | Leukotriene B4 results in increased expression of CCL2 protein | increases expression | 19880577 |
| D007975 | Leukotriene B4 | zileuton inhibits the reaction [CCL2 protein results in increased abundance of Leukotriene B4] | decreases reaction|increases abundance | 12388339 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of CCL2 mRNA | increases expression | 16129981 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of CCL2 protein | increases expression | 16129981 |
| D006851 | Hydrochloric Acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16129981 |
| D006851 | Hydrochloric Acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16129981 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [ALB protein results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 11961005 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CCL2 mRNA | increases expression | 16143069 12419474 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CCL2 protein | increases expression | 17529908 |
| D006861 | Hydrogen Peroxide | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D006861 | Hydrogen Peroxide | Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| C031927 | hydroquinone | hydroquinone results in increased expression of CCL2 protein | increases expression | 17572062 |
| D006886 | Hydroxychloroquine | Hydroxychloroquine results in increased expression of CCL2 mRNA | increases expression | 15139008 |
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone affects the expression of CCL2 protein | affects expression | 17572062 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of CCL2 mRNA | increases expression | 17070997 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18799549 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18799549 |
| D007052 | Ibuprofen | Ibuprofen results in decreased expression of CCL2 mRNA | decreases expression | 15552841 |
| D019469 | Indinavir | diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| D019469 | Indinavir | Indinavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18799549 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18799549 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18799549 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18799549 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | affects cotreatment|increases expression | 17572062 |
| D007501 | Iron | Iron deficiency results in increased expression of CCL2 mRNA | increases expression | 20368581 |
| D007501 | Iron | [Iron co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 20302851 |
| D007501 | Iron | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | affects cotreatment|increases expression|increases reaction | 20302851 |
| D019266 | Iron, Dietary | Iron, Dietary affects the expression of CCL2 mRNA | affects expression | 18032466 |
| D019266 | Iron, Dietary | Iron, Dietary affects the reaction [Thioacetamide affects the expression of CCL2 mRNA] | affects expression|affects reaction | 18032466 |
| D015056 | 1-Methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA | decreases expression | 19141685 |
| D015056 | 1-Methyl-3-isobutylxanthine | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D015056 | 1-Methyl-3-isobutylxanthine | Calcimycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | affects cotreatment|decreases expression | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D007530 | Isoflurane | Isoflurane results in decreased expression of CCL2 mRNA | decreases expression | 15564938 |
| C016527 | isoquercitrin | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| C006552 | kaempferol | kaempferol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16434028 |
| C006552 | kaempferol | kaempferol inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16434028 |
| C482199 | lipopolysaccharide, E coli O55-B5 | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 17880982 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein | increases expression | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Quercetin inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17880982 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein | increases expression | 17526599 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA | increases expression | 15734790 12954792 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 protein | increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12954792 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 15734790 |
| D008070 | Lipopolysaccharides | 1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| D008070 | Lipopolysaccharides | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 15698426 |
| D008070 | Lipopolysaccharides | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| D008070 | Lipopolysaccharides | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 16317058 |
| D008070 | Lipopolysaccharides | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16317058 |
| D008070 | Lipopolysaccharides | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17529908 |
| D008070 | Lipopolysaccharides | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17529908 |
| D008070 | Lipopolysaccharides | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15698426 |
| D008070 | Lipopolysaccharides | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15698426 |
| D008070 | Lipopolysaccharides | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15698426 |
| D008070 | Lipopolysaccharides | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15698426 |
| D008070 | Lipopolysaccharides | Gentamicins inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17699551 |
| D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17699551 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the secretion of CCL2 protein | affects secretion | 15196211 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | increases expression | 17529908 17699551 15698426 16317058 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | increases expression | 17529908 17699551 15788441 15698426 |
| D008070 | Lipopolysaccharides | CP 105696 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19880577 |
| D008070 | Lipopolysaccharides | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16306350 |
| D008070 | Lipopolysaccharides | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 15968640 |
| D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17442725 |
| D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | increases expression|increases reaction | 17442725 |
| D008070 | Lipopolysaccharides | IFNB1 protein affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | affects reaction|increases secretion | 15804595 |
| D008070 | Lipopolysaccharides | LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18292240 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | increases expression | 20423518 19136613 18292240 17699551 10223745 18323514 10027076 17442725 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | increases expression | 19880577 17442725 19020770 18706406 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CCL2 protein | increases secretion | 15593098 9973430 16303184 |
| D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 20423518 |
| D008070 | Lipopolysaccharides | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16306350 |
| D008070 | Lipopolysaccharides | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18706406 |
| D008070 | Lipopolysaccharides | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| D008070 | Lipopolysaccharides | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | increases expression | 11340305 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | increases expression | 11340305 15721863 |
| D008070 | Lipopolysaccharides | Sodium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D008070 | Lipopolysaccharides | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19243473 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | increases expression | 19243473 |
| C112035 | lopinavir | diphenyleneiodonium inhibits the reaction [lopinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| C112035 | lopinavir | lopinavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| D019808 | Losartan | Losartan results in decreased expression of CCL2 mRNA | decreases expression | 10925121 |
| D017997 | Leukotriene C4 | Leukotriene C4 results in increased expression of CCL2 mRNA | increases expression | 12388339 |
| C013592 | mangiferin | mangiferin results in decreased expression of CCL2 mRNA | decreases expression | 15135318 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CCL2 mRNA | increases expression | 20713471 |
| D020366 | Methylmethacrylate | Methylmethacrylate results in increased expression of CCL2 mRNA | increases expression | 17498896 |
| D008770 | Methylnitrosourea | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CCL2 protein | increases expression | 16822543 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CCL2 mRNA | increases expression | 17412507 |
| C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 19158351 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CCL2 mRNA | decreases expression | 16507463 |
| C093875 | montelukast | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | decreases reaction|increases abundance | 16771778 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 protein | increases expression | 17720292 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | increases expression | 18955075 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | increases expression | 8796382 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 protein | increases expression | 9187966 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | increases expression | 18988085 |
| C063008 | mycophenolate mofetil | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17624267 |
| C063008 | mycophenolate mofetil | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17624267 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 11230753 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 11230753 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 11230753 |
| D019888 | Nelfinavir | diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| D019888 | Nelfinavir | Nelfinavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| C022838 | nickel chloride | nickel chloride results in decreased expression of CCL2 mRNA | decreases expression | 12839937 |
| C017557 | nickel subsulfide | nickel subsulfide results in decreased expression of CCL2 mRNA | decreases expression | 12760830 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of CCL2 mRNA | increases expression | 16780908 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of CCL2 mRNA | increases expression | 16100012 |
| C007350 | nitrofen | nitrofen results in increased expression of CCL2 protein | increases expression | 15110079 |
| D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased expression of CCL2 mRNA | increases expression | 10715624 |
| D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased expression of CCL2 protein | increases expression | 11498801 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of CCL2 mRNA | increases expression | 17616710 |
| D019787 | Linoleic Acid | Linoleic Acid results in increased expression of CCL2 protein | increases expression | 16305726 |
| C120126 | oil fly ash | 1,3-dimethylthiourea inhibits the reaction [oil fly ash results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 14569496 |
| C120126 | oil fly ash | oil fly ash results in increased expression of CCL2 mRNA | increases expression | 14569496 |
| D010047 | Ovalbumin | Ovalbumin results in increased expression of CCL2 mRNA | increases expression | 12388339 12794006 |
| D010047 | Ovalbumin | PH 163 inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| D010047 | Ovalbumin | verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 mRNA | increases expression | 18436887 |
| D010100 | Oxygen | Oxygen results in increased expression of CCL2 protein | increases expression | 11498801 |
| D010100 | Oxygen | valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18436887 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein | increases expression|increases secretion | 18803305 |
| D010100 | Oxygen | phenylmethylpyrazolone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | decreases reaction|increases expression|increases secretion | 18803305 |
| D010100 | Oxygen | SDC2 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | increases expression|increases reaction|increases secretion | 18803305 |
| D010126 | Ozone | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17460151 |
| D010126 | Ozone | CPE gene mutant form promotes the reaction [Ozone results in increased expression of CCL2 protein] | increases expression|increases reaction | 16002559 |
| D010126 | Ozone | Endotoxins promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 12217210 |
| D010126 | Ozone | Ozone results in increased expression of CCL2 mRNA | increases expression | 12763052 12217210 9458799 17307210 14754758 15371095 |
| D010126 | Ozone | Ozone results in increased expression of CCL2 protein | increases expression | 18929643 11498801 17575079 16002559 |
| D010126 | Ozone | Ozone results in increased expression of CCL2 mRNA | increases expression | 9458799 16716893 |
| D010269 | Paraquat | Paraquat results in increased expression of CCL2 mRNA | increases expression | 16324872 |
| C002669 | parthenolide | parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15728586 |
| C073402 | PD 123319 | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15284299 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12016129 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased secretion of CCL2 protein | increases secretion | 15593098 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 17191021 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 17191021 |
| C104857 | PH 163 | PH 163 inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 20423518 |
| D010656 | Phenylephrine | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15721863 |
| D010656 | Phenylephrine | parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15728586 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CCL2 mRNA | increases expression | 15728586 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CCL2 protein | increases expression | 15721863 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12954792 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | decreases reaction|increases expression|increases secretion | 18803305 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CCL2 protein] | decreases reaction|increases expression|increases secretion | 18803305 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of CCL2 mRNA | decreases expression | 15948865 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of CCL2 protein | decreases expression | 19381132 |
| D010672 | Phenytoin | Phenytoin results in increased expression of CCL2 protein | increases expression | 14578793 |
| D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL3 mRNA] | increases expression|increases reaction | 11937571 |
| D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL4 mRNA] | increases expression|increases reaction | 11937571 |
| D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 11937571 |
| D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CXCL2 mRNA] | increases expression|increases reaction | 11937571 |
| D010743 | Phospholipids | CCL2 protein results in increased susceptibility to Phospholipids | increases response to substance | 11937571 |
| D010743 | Phospholipids | Phospholipids results in increased expression of CCL2 mRNA | increases expression | 11937571 |
| C043103 | phthalic anhydride | phthalic anhydride results in increased expression of CCL2 protein | increases expression | 20219652 |
| D010880 | Piperidines | Piperidines analog inhibits the reaction [CCL2 protein binds to CCR2 protein] | affects binding|decreases reaction | 10770925 |
| D010880 | Piperidines | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | decreases reaction|increases uptake | 10843593 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of CCL2 mRNA | affects expression | 16306350 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15814532 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16306350 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16306350 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CCL2 mRNA | decreases expression | 17888025 18356826 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CCL2 protein | decreases expression | 17888025 18356826 |
| C108475 | pitavastatin | pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| C108475 | pitavastatin | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| C467566 | pomalidomide | pomalidomide results in increased secretion of CCL2 protein | increases secretion | 15292067 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18323514 |
| D011374 | Progesterone | Progesterone affects the expression of CCL2 mRNA | affects expression | 17251523 |
| C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16705055 |
| C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15284299 |
| D015232 | Dinoprostone | Dinoprostone results in decreased expression of CCL2 mRNA | decreases expression | 16303787 |
| D011464 | Epoprostenol | Epoprostenol results in increased expression of CCL2 protein | increases expression | 15302794 |
| C003243 | psicose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17655880 |
| C003243 | psicose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17655880 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11961005 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IL17A protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12016129 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16129981 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16129981 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17880982 |
| D011794 | Quercetin | Quercetin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17103373 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18489909 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18489909 16794257 |
| D011794 | Quercetin | Quercetin results in decreased secretion of CCL2 protein | decreases secretion | 17191019 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19735175 |
| D011794 | Quercetin | Quercetin results in decreased expression of CCL2 protein | decreases expression | 16794257 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 10541287 |
| D011794 | Quercetin | Quercetin results in decreased expression of CCL2 mRNA | decreases expression | 10925121 |
| D011794 | Quercetin | Quercetin results in decreased expression of CCL2 protein | decreases expression | 11053056 |
| D020849 | Raloxifene | fulvestrant inhibits the reaction [Raloxifene results in decreased activity of CCL2 protein] | decreases activity|decreases reaction | 17006379 |
| D020849 | Raloxifene | Raloxifene affects the expression of CCL2 mRNA | affects expression | 14699072 |
| D020849 | Raloxifene | [Raloxifene co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 19059307 |
| D020849 | Raloxifene | Raloxifene results in decreased activity of CCL2 protein | decreases activity | 17006379 |
| D017382 | Reactive Oxygen Species | RAC1 protein promotes the reaction [Reactive Oxygen Species promotes the reaction [TNF protein results in increased expression of CCL2 mRNA]] | increases expression|increases reaction | 14576080 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species promotes the reaction [TNF protein results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 14576080 |
| C059514 | resveratrol | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression | 17191021 |
| C059514 | resveratrol | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] | decreases reaction|increases secretion | 17191021 |
| C059514 | resveratrol | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | affects localization|decreases reaction | 16212921 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17191021 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 17191021 |
| C059514 | resveratrol | resveratrol analog results in decreased expression of CCL2 mRNA | decreases expression | 15652768 |
| C059514 | resveratrol | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17374693 |
| C059514 | resveratrol | resveratrol results in decreased expression of CCL2 protein | decreases expression | 17872969 |
| C059514 | resveratrol | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 15734790 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of CCL2 mRNA | decreases expression | 15972972 |
| D019438 | Ritonavir | diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17668557 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CCL2 protein | increases expression | 17668557 |
| C116926 | rofecoxib | rofecoxib results in increased expression of CCL2 mRNA | increases expression | 17070997 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | affects cotreatment|decreases expression | 16054899 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of CCL2 mRNA | decreases expression | 16306350 |
| C089730 | rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| C010327 | salinomycin | salinomycin results in decreased expression of CCL2 mRNA | decreases expression | 19682730 |
| C057823 | salmeterol | salmeterol promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 15531761 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18645721 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 17655880 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12016129 |
| C018145 | scoparone | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16376386 |
| C018145 | scoparone | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16376386 |
| D012643 | Selenium | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D012643 | Selenium | Selenium inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D012643 | Selenium | Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16143069 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased expression of CCL2 protein | increases expression | 17200189 |
| D017632 | Asbestos, Serpentine | PRKDC affects the reaction [Asbestos, Serpentine results in increased expression of CCL2 protein] | affects reaction|increases expression | 17200189 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased expression of CCL2 mRNA | increases expression | 10923243 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased expression of CCL2 protein | increases expression | 10923243 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased secretion of CCL2 protein | increases secretion | 10923243 |
| D017632 | Asbestos, Serpentine | IL1B protein promotes the reaction [Asbestos, Serpentine results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10923243 |
| D017632 | Asbestos, Serpentine | IL1B protein promotes the reaction [Asbestos, Serpentine results in increased secretion of CCL2 protein] | increases reaction|increases secretion | 10923243 |
| D017632 | Asbestos, Serpentine | TNF protein promotes the reaction [Asbestos, Serpentine results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10923243 |
| D017632 | Asbestos, Serpentine | TNF protein promotes the reaction [Asbestos, Serpentine results in increased secretion of CCL2 protein] | increases reaction|increases secretion | 10923243 |
| C009250 | sevoflurane | sevoflurane results in decreased expression of CCL2 mRNA | decreases expression | 15564938 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19225232 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 mRNA | decreases expression | 19225232 |
| D019821 | Simvastatin | [valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 19225232 |
| D012906 | Smoke | Smoke results in increased secretion of CCL2 protein | increases secretion | 17041012 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [ALB protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 11340305 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein] | decreases expression|decreases reaction | 11340305 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| D012964 | Sodium | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CCL2 mRNA | decreases expression | 16507463 12760830 12016162 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of CCL2 mRNA | decreases expression | 12760830 |
| C110630 | SR 144528 | SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491 |
| C110630 | SR 144528 | SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 10218491 |
| C031183 | stearic acid | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17374693 |
| C031183 | stearic acid | stearic acid results in increased expression of CCL2 mRNA | increases expression | 17374693 |
| D013311 | Streptozocin | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17624267 |
| D013311 | Streptozocin | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17624267 |
| D013311 | Streptozocin | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15284299 |
| D013311 | Streptozocin | prolinedithiocarbamate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15284299 |
| D013311 | Streptozocin | Streptozocin results in increased expression of CCL2 mRNA | increases expression | 17624267 15284299 16684804 |
| D013311 | Streptozocin | Streptozocin results in increased expression of CCL2 protein | increases expression | 17624267 |
| D013311 | Streptozocin | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17624267 15284299 |
| D013311 | Streptozocin | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17624267 |
| D013311 | Streptozocin | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16684804 |
| D010042 | Ouabain | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| D010042 | Ouabain | Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D010042 | Ouabain | Ouabain results in increased expression of CCL2 mRNA | increases expression | 11340305 |
| D010042 | Ouabain | Ouabain results in increased expression of CCL2 protein | increases expression | 11340305 |
| D010042 | Ouabain | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11340305 |
| D010042 | Ouabain | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11340305 |
| D020058 | Styrene | Styrene results in increased expression of CCL2 mRNA | increases expression | 15212811 |
| D020058 | Styrene | Styrene results in increased expression of CCL2 protein | increases expression | 15212811 17993253 |
| D013481 | Superoxides | Superoxides affects the reaction [Fructose results in increased secretion of CCL2 protein] | affects reaction|increases secretion | 19158351 |
| D013481 | Superoxides | 1,3-dimethylthiourea inhibits the reaction [Superoxides results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 8856246 |
| D013481 | Superoxides | Superoxides results in increased expression of CCL2 mRNA | increases expression | 8856246 |
| C030192 | tagatose | tagatose results in increased secretion of CCL2 protein | increases secretion | 19158351 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 19059307 |
| C041348 | tcdA protein, Clostridium difficile | astressin-2B inhibits the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16920976 |
| C041348 | tcdA protein, Clostridium difficile | CRHR2 protein affects the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA] | affects reaction|increases expression | 16920976 |
| C041348 | tcdA protein, Clostridium difficile | tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA | increases expression | 16920976 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | increases expression | 19372248 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | decreases expression | 16054899 15591033 19933214 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | increases expression | 17320037 19372248 18606429 |
| D013755 | Tetradecanoylphorbol Acetate | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | affects cotreatment|increases expression | 17572062 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | increases expression | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein | increases secretion | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | increases expression | 19063610 |
| C019107 | tetramethylthiourea | tetramethylthiourea results in decreased expression of CCL2 mRNA | decreases expression | 11128050 |
| C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 15541506 |
| C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15541506 |
| D019284 | Thapsigargin | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D019284 | Thapsigargin | Thapsigargin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18799549 |
| D019284 | Thapsigargin | Thapsigargin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18799549 |
| D013853 | Thioacetamide | Iron, Dietary affects the reaction [Thioacetamide affects the expression of CCL2 mRNA] | affects expression|affects reaction | 18032466 |
| D013864 | Thioglycolates | ADIPOQ gene affects the reaction [Thioglycolates results in increased secretion of CCL2 protein] | affects reaction|increases secretion | 18628355 |
| D013864 | Thioglycolates | CCL2 gene affects the susceptibility to Thioglycolates | affects response to substance | 19641140 |
| D013864 | Thioglycolates | [CCL2 gene affects the susceptibility to Thioglycolates] which affects the secretion of CCL7 protein | affects response to substance|affects secretion | 19641140 |
| D013864 | Thioglycolates | Thioglycolates results in increased secretion of CCL2 protein | increases secretion | 9973430 19641140 18628355 |
| D014025 | Titanium | Titanium results in increased expression of CCL2 mRNA | increases expression | 16392133 |
| D014025 | Titanium | Titanium results in increased secretion of CCL2 protein | increases secretion | 16392133 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of CCL2 protein | increases expression | 20219652 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 11698246 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 11698246 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16600694 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | decreases reaction|increases secretion | 16600694 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL17A protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12016129 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18706406 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of CCL2 mRNA | decreases expression | 12846738 |
| D014212 | Tretinoin | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA | affects cotreatment|increases expression | 19828696 |
| D014212 | Tretinoin | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 protein | affects cotreatment|increases expression | 19828696 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 mRNA | decreases expression | 16054129 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CCL2 mRNA | increases expression | 19828696 17218384 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CCL2 protein | increases expression | 17118196 19828696 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 mRNA | decreases expression | 16412693 |
| D014212 | Tretinoin | Tretinoin results in decreased secretion of CCL2 protein | decreases secretion | 16096774 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA | increases expression | 17982090 |
| D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of CCL2 mRNA | affects expression | 21346803 |
| C030665 | triphenyltin | triphenyltin results in increased expression of CCL2 mRNA | increases expression | 12788061 |
| C057693 | troglitazone | troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 15531761 |
| C057693 | troglitazone | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | decreases secretion|increases reaction | 17719033 |
| D014415 | Tunicamycin | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | decreases expression|decreases reaction | 19141685 |
| D014415 | Tunicamycin | Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 18799549 |
| C113580 | U 0126 | U 0126 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 12016129 |
| D014501 | Uranium | Uranium results in decreased expression of CCL2 protein | decreases expression | 16854789 |
| D014527 | Uric Acid | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | affects cotreatment|decreases reaction|increases secretion | 19158351 |
| D014527 | Uric Acid | [Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein | affects cotreatment|increases secretion | 19158351 |
| D014527 | Uric Acid | Uric Acid results in increased secretion of CCL2 protein | increases secretion | 19158351 |
| C081489 | valsartan | [valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 19225232 |
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 19225232 16705055 |
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16705055 |
| C081489 | valsartan | valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 19225232 |
| C081489 | valsartan | valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 18436887 |
| C081489 | valsartan | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 17624267 15284299 |
| C081489 | valsartan | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | decreases reaction|increases expression | 17624267 |
| D014638 | Vanadates | Vanadates results in increased expression of CCL2 mRNA | increases expression | 19063610 |
| C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of CCL2 mRNA | increases expression | 16330358 |
| C034028 | vanadyl sulfate | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 16684804 |
| C059141 | verlukast | verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| D014801 | Vitamin A | Vitamin A results in decreased expression of CCL2 protein | decreases expression | 16988133 |
| D014810 | Vitamin E | alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19735175 |
| D014810 | Vitamin E | Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | decreases reaction|increases expression | 19735175 |
| D014810 | Vitamin E | Vitamin E deficiency results in increased expression of CCL2 protein | increases expression | 19735175 |
| D015215 | Zidovudine | Zidovudine results in increased expression of CCL2 protein | increases expression | 17668557 |
| C063449 | zileuton | zileuton inhibits the reaction [CCL2 protein results in increased abundance of Leukotriene B4] | decreases reaction|increases abundance | 12388339 |
| C063449 | zileuton | zileuton inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | decreases reaction|increases expression | 12794006 |
| C088658 | zoledronic acid | zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] | decreases expression|increases reaction | 19825521 |
| D015054 | Zymosan | Zymosan affects the secretion of CCL2 protein | affects secretion | 15196211 |
| D015054 | Zymosan | Zymosan results in increased secretion of CCL2 protein | increases secretion | 15196211 |
| D015054 | Zymosan | CCL2 gene affects the susceptibility to Zymosan | affects response to substance | 19641140 |
| D015054 | Zymosan | CCR2 protein affects the reaction [Zymosan results in increased expression of CCL2 protein] | affects reaction|increases expression | 12845637 |
| D015054 | Zymosan | Zymosan results in increased expression of CCL2 mRNA | increases expression | 9973430 14507659 |
| D015054 | Zymosan | Zymosan results in increased expression of CCL2 protein | increases expression | 17572156 12845637 |
| D015054 | Zymosan | Zymosan results in increased secretion of CCL2 protein | increases secretion | 9973430 19641140 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.18 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 16.46 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 16.46 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | mycophenolate mofetil | 16.46 | 18238994 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 16.46 | 3425630 8986270 10563481 6195326 9118846 9677735 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 16.46 | 11752688 15322242 14514962 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Trinitrotoluene | 16.46 | 7525203 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 6.63 | 18769834 | |
| MESH:D000015 | Abnormalities, Multiple | Vitamin A | 6.63 | 10992263 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 6.31 | 18287403 | |
| MESH:D000138 | Acidosis | Hydrochloric Acid | 6.31 | 16144966 20872349 11574821 15920416 19262391 12771618 | |
| MESH:D000141 | Acidosis, Renal Tubular | Hydrochloric Acid | 4.45 | 17183249 | |
| MESH:D000142 | Acidosis, Respiratory | Hydrochloric Acid | 4.45 | 20597076 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 4.91 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 12.64 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 12.64 | 18769834 16185265 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 12.64 | 20436887 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.51 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.16 | 17694057 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 25.73 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 25.73 | 15814532 17670903 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 25.73 | 16316344 16595132 17003819 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 25.73 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 25.73 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 25.73 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Superoxides | 25.73 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 25.73 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | 3-xylene | 37.84 | 15204773 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 37.84 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Bleomycin | 37.84 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | Hydrochloric Acid | 37.84 | 19060228 15970105 19094174 11850527 16759491 19760209 11953099 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 37.84 | 18653653 11850527 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 37.84 | 16100012 12718980 19131640 11954676 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 37.84 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 37.84 | 18653653 | |
| MESH:D055371 | Acute Lung Injury | verlukast | 37.84 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 37.84 | 17118201 | |
| MESH:D000210 | Acute-Phase Reaction | Thioglycolates | 8.72 | 9464241 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 8.72 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 21.48 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 21.48 | 20464547 20127859 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 21.48 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 21.48 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 21.48 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 21.48 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 21.48 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 21.48 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 21.48 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 21.48 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 21.48 | 15688392 15113128 | |
| MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 27.24 | 3712494 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 27.24 | 16176798 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 27.24 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 27.24 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 27.24 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 27.24 | 19555203 | |
| MESH:D000236 | Adenoma | Folic Acid | 27.24 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 27.24 | 11497255 | |
| MESH:D000236 | Adenoma | Methylcholanthrene | 27.24 | 10545420 6695378 | |
| MESH:D000236 | Adenoma | resveratrol | 27.24 | 15688382 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 9.62 | 19052882 17162532 16434500 17620307 19061943 18056438 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 9.62 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.62 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 9.60 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 9.60 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Leukotriene B4 | 9.60 | 17942926 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.34 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.28 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.28 | 17306315 16712894 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 2.51 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 12.01 | 21441931 | |
| MESH:D000419 | Albuminuria | Losartan | 12.01 | 12586211 | |
| MESH:D000419 | Albuminuria | Raloxifene | 12.01 | 17308373 17451421 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.72 | 17887948 | |
| MESH:D000505 | Alopecia | Capsaicin | 5.73 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.73 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.30 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.00 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 19.84 | 17570602 15207723 14715435 | |
| MESH:D000544 | Alzheimer Disease | Copper | 19.84 | 17119284 16886094 16410023 16962711 16325427 16866297 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 19.84 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 19.84 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 19.84 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 19.84 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 19.84 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 19.84 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 19.84 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 19.84 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | rosiglitazone | 19.84 | 19621015 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.19 | 15469931 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 3.31 | 10694572 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 7.73 | 9532969 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 7.73 | 14669257 16536907 | |
| MESH:D000740 | Anemia | Iron | 11.40 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 11.40 | 11748828 | |
| MESH:D000740 | Anemia | Vitamin A | 11.40 | 16960172 | |
| MESH:D000740 | Anemia | Zymosan | 11.40 | 18664788 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.23 | 14761424 17661222 11369114 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.00 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 9.86 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 9.86 | 17163184 16569441 17375513 17147795 17162259 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Vitamin A | 9.86 | 16960172 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 7.11 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Superoxides | 7.11 | 16910769 | |
| MESH:D000799 | Angioedema | Acetaminophen | 12.78 | 10982225 | |
| MESH:D000799 | Angioedema | montelukast | 12.78 | 10982225 | |
| MESH:D000799 | Angioedema | salmeterol | 12.78 | 10982225 | |
| MESH:D000860 | Anoxia | Bleomycin | 11.23 | 15782499 | |
| MESH:D000860 | Anoxia | Hydrochloric Acid | 11.23 | 15090967 | |
| MESH:D000860 | Anoxia | Oxygen | 11.23 | 20872349 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 7.91 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 7.91 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 12.55 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 12.55 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 12.55 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Amiodarone | 8.07 | 18057881 18218290 20041841 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 8.07 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 8.07 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.30 | 12569548 16835338 18414634 16251483 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 5.99 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 5.99 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.81 | 2160914 | |
| MESH:D001168 | Arthritis | Leukotriene B4 | 4.83 | 11006272 | |
| MESH:D001169 | Arthritis, Experimental | Carrageenan | 22.98 | 17392412 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 22.98 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 22.98 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 22.98 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | rofecoxib | 22.98 | 16690336 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 22.98 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 22.98 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 22.98 | 15142272 15188379 15944321 17659584 16872482 | |
| MESH:D015210 | Arthritis, Gouty | Uric Acid | 5.38 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 7.55 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 7.55 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 7.55 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 7.55 | 16390820 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 7.55 | 16292516 | |
| MESH:D001195 | Asbestosis | Asbestos, Serpentine | 4.37 | 10751356 | |
| MESH:D001249 | Asthma | marker/mechanism | 19373627 | ||
| MESH:D001249 | Asthma | Acetaldehyde | 29.25 | 9600491 | |
| MESH:D001249 | Asthma | Budesonide | 29.25 | 15572850 12113382 15136378 20004779 18489783 10893010 12604023 | |
| MESH:D001249 | Asthma | fluticasone | 29.25 | 11991558 11596838 11101185 | |
| MESH:D001249 | Asthma | Leukotriene B4 | 29.25 | 19667530 11006272 | |
| MESH:D001249 | Asthma | montelukast | 29.25 | 10852428 17895592 16293801 20332717 19681236 19667530 | |
| MESH:D001249 | Asthma | Mustard Gas | 29.25 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 29.25 | 16373670 17854713 | |
| MESH:D001249 | Asthma | phthalic anhydride | 29.25 | 3681491 | |
| MESH:D001249 | Asthma | salmeterol | 29.25 | 10359889 11694805 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 29.25 | 8156442 6091945 16210060 11467998 6091946 15590891 19187332 11077013 3040596 12762349 7684630 16792590 18394133 11742282 17015710 12585506 10934080 15590890 170078 20032816 12684321 15855793 10797510 | |
| MESH:D001249 | Asthma | Tretinoin | 29.25 | 16456186 | |
| MESH:D001249 | Asthma | Vitamin A | 29.25 | 16732791 | |
| MESH:D001249 | Asthma | zileuton | 29.25 | 19214143 9620945 8598621 17944539 10764316 20332717 10181070 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 6.66 | 20485159 12372130 | |
| MESH:D055963 | Asthma, Aspirin-Induced | montelukast | 6.66 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | Leukotriene B4 | 16.63 | 19667531 | |
| MESH:D001250 | Asthma, Exercise-Induced | montelukast | 16.63 | 10984370 19667531 | |
| MESH:D001250 | Asthma, Exercise-Induced | salmeterol | 16.63 | 10984370 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 16.63 | 10984370 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 8.66 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 8.66 | 15336622 | |
| MESH:D050197 | Atherosclerosis | marker/mechanism | 12928151 | ||
| MESH:D050197 | Atherosclerosis | Acrolein | 29.58 | 16126721 16037261 17363696 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 29.58 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Asbestos | 29.58 | 18795166 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 29.58 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 29.58 | 16640825 16632123 | |
| MESH:D050197 | Atherosclerosis | Losartan | 29.58 | 10821809 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 29.58 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Methylcholanthrene | 29.58 | 11922910 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 29.58 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 29.58 | 15136057 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 29.58 | 17967414 16873680 | |
| MESH:D001281 | Atrial Fibrillation | Amiodarone | 2.79 | 18651412 19698954 | |
| MESH:D001284 | Atrophy | fulvestrant | 3.56 | 11514358 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Fatty Acids, Omega-3 | 3.79 | 18448859 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 3.70 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Choline | 3.70 | 16818868 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 3.70 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Fatty Acids, Omega-3 | 3.70 | 16920077 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 3.70 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Homocysteine | 3.70 | 20468076 16297937 | |
| MESH:D001321 | Autistic Disorder | Iron | 3.70 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Linoleic Acid | 3.70 | 18582451 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 6.52 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 6.52 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.86 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.10 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 8.32 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 8.32 | 10684365 | |
| MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 3.65 | 11289319 1440618 | |
| MESH:D001768 | Blister | Mustard Gas | 3.81 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | Amiodarone | 29.24 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 29.24 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 29.24 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Hydrochloric Acid | 29.24 | 15920416 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 29.24 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 29.24 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 29.24 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 29.24 | 16197459 16206674 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.43 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.75 | 15746008 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.87 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 12.63 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 12.63 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 12.63 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 3.70 | 19442620 11697798 15867366 16121404 16778634 17312309 | |
| MESH:D001862 | Bone Resorption | Berberine | 16.65 | 9881647 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 16.65 | 11985600 | |
| MESH:D001862 | Bone Resorption | Freund's Adjuvant | 16.65 | 16769263 | |
| MESH:D001862 | Bone Resorption | mangiferin | 16.65 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 16.65 | 18404659 11869084 18496637 15845617 8053405 16769263 | |
| MESH:D001919 | Bradycardia | Capsaicin | 6.50 | 18207255 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 6.50 | 15306635 | |
| MESH:D001929 | Brain Edema | Indomethacin | 8.37 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 8.37 | 19309543 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.97 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 6.61 | 15665606 15380490 15845082 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 6.61 | 16580743 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 17.88 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 17.88 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 17.88 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 17.88 | 12524144 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 17.88 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Acrylonitrile | 18.47 | 12562636 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 18.47 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Carmustine | 18.47 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | Copper | 18.47 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 18.47 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 18.47 | 17150277 | |
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 33.94 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 33.94 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 33.94 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 33.94 | 11921183 17162533 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 33.94 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 33.94 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 33.94 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Copper | 33.94 | 15986119 17079463 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 33.94 | 18462866 18593918 16243823 19250217 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 33.94 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 33.94 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 33.94 | 15136595 17426702 18628466 16935488 16096432 16264153 17369602 15567936 11325840 15634643 15668708 15939500 16115903 15993339 19526202 18234424 17983394 18382427 16322301 15692762 16826403 16595493 15994142 18695136 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 33.94 | 17018787 19861407 14630087 17261762 17289903 16675129 18497071 12948864 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 33.94 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 33.94 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 33.94 | 16541309 17200150 16873071 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 33.94 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 33.94 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 33.94 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 33.94 | 14633655 16253758 11306469 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 33.94 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | parthenolide | 33.94 | 16873071 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 33.94 | 17614352 16175315 15562024 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 33.94 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 33.94 | 17261762 15758505 15775269 16912660 17893378 17440819 15572757 17049068 17952589 16837676 17595753 17242785 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 33.94 | 17651959 17534123 16393696 | |
| MESH:D001943 | Breast Neoplasms | salinomycin | 33.94 | 19682730 | |
| MESH:D001943 | Breast Neoplasms | Styrene | 33.94 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 33.94 | 19189212 19155303 19487384 18629630 19221464 18855134 19084267 18425577 19011961 20005174 17261762 18351453 15668708 19115204 18815881 20135344 19189210 18984771 15565566 19142967 19288272 20544844 17049068 16202921 20390343 11161223 17893378 19103187 19289846 16273361 21152245 21138602 19059307 19200415 20859285 17242785 16873071 17440819 19066611 16818667 19244106 18997820 18821012 20065188 19410462 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 33.94 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 33.94 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 33.94 | 16166294 16443354 16873071 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 33.94 | 16096432 18695136 | |
| MESH:D016535 | Bronchial Hyperreactivity | marker/mechanism | 12388339 | ||
| MESH:D016535 | Bronchial Hyperreactivity | Hydrochloric Acid | 30.75 | 12378975 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene B4 | 30.75 | 12794006 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene C4 | 30.75 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ovalbumin | 30.75 | 12794006 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 30.75 | 17626835 16777450 19059883 14754758 18417511 18315731 15516495 | |
| MESH:D016535 | Bronchial Hyperreactivity | PH 163 | 30.75 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 30.75 | 8156442 15590891 12507178 | |
| MESH:D016535 | Bronchial Hyperreactivity | verlukast | 30.75 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 30.75 | 12794006 12654629 12388339 | |
| MESH:D001986 | Bronchial Spasm | Hydrochloric Acid | 8.07 | 15578804 | |
| MESH:D001986 | Bronchial Spasm | verlukast | 8.07 | 11432448 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.81 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | fluticasone | 15.09 | 17687719 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 15.09 | 10378619 17687719 | |
| MESH:D029481 | Bronchitis, Chronic | salmeterol | 15.09 | 17687719 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 8.57 | 16813970 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Vitamin A | 8.57 | 17377406 17426644 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.05 | 11589617 | |
| MESH:D002056 | Burns | Indomethacin | 3.39 | 10459503 | |
| MESH:D002100 | Cachexia | Ibuprofen | 13.45 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 13.45 | 15625704 15141370 16537180 11239499 | |
| MESH:D002100 | Cachexia | Ozone | 13.45 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.18 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.12 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 5.60 | 16227642 16124888 15721981 16011737 10355542 16097048 15700767 16192424 15673190 3786805 18705752 16050911 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 5.60 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 8.19 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 8.19 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 10.60 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 10.60 | 19555203 | |
| MESH:D002277 | Carcinoma | Methylcholanthrene | 10.60 | 10545420 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 10.60 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.65 | 15504454 17687452 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.18 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.79 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 33.17 | 3581430 7296757 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 33.17 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 33.17 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 33.17 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 33.17 | 16217749 11135700 14691202 15073043 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 33.17 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 33.17 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 33.17 | 19335982 16502159 19519916 20727157 20524982 16540662 16807293 16830150 3084413 19418558 19383236 20512989 18785209 18665156 18494052 18978308 21159647 20514400 20432363 16698587 20084675 16328049 18691550 19539802 11831363 18506893 10737359 20214788 19394651 16935385 20101231 19919837 17761372 19701751 16681979 16569478 18971187 18788625 19822196 10672840 19052882 19208518 18393292 16878318 16779866 17173139 18210153 16288022 20935162 17055752 20007298 17138121 17162532 19171122 19107877 17978847 18056438 17428255 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 33.17 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 33.17 | 16023760 18059187 17876044 16234567 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 33.17 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 33.17 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 33.17 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 33.17 | 19519916 12508355 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 33.17 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 33.17 | 17306315 15276417 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 33.17 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 33.17 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 33.17 | 1917145 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.64 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 7.00 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 7.00 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.00 | 11352223 14736730 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 4.84 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 4.84 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 4.84 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.63 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.51 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 10.94 | 7296757 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 10.94 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 10.94 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 10.94 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 10.94 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.89 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 31.19 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 31.19 | 18922899 17687452 15504454 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 31.19 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Bleomycin | 31.19 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 31.19 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 31.19 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 31.19 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 31.19 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 31.19 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 31.19 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 31.19 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 31.19 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 31.19 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 31.19 | 16096774 16051514 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 12.79 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 12.79 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 12.79 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 12.79 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 14.49 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Losartan | 14.49 | 12586211 15969258 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 14.49 | 17287366 11179087 16170337 11754973 15728586 17124262 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 14.49 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 14.49 | 18670907 18850075 16120746 | |
| MESH:D006332 | Cardiomegaly | valsartan | 14.49 | 19597038 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 10.10 | 16731534 17007740 15505089 16364871 16651473 16455267 15811867 15476868 15792986 16269455 16109756 18627295 16612575 16242529 16952015 17519947 16278810 17351982 17924179 17131338 17382496 17329180 17928571 17308081 17974986 | |
| MESH:D009202 | Cardiomyopathies | Iron | 10.10 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | tetrathiomolybdate | 10.10 | 16242529 | |
| MESH:D009202 | Cardiomyopathies | valsartan | 10.10 | 16247790 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 5.11 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Amiodarone | 5.34 | 19225199 15710769 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 5.34 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 5.34 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | marker/mechanism | 16332659 | ||
| MESH:D002318 | Cardiovascular Diseases | Acarbose | 25.14 | 17133782 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 25.14 | 17938729 15738583 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 25.14 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 25.14 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 25.14 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 25.14 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 25.14 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 25.14 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | valsartan | 25.14 | 11230374 | |
| MESH:D002340 | Carotid Artery Diseases | marker/mechanism | 18022660 | ||
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.11 | 18022660 16973168 | |
| MESH:D002341 | Carotid Artery Thrombosis | Amiodarone | 3.74 | 18974383 | |
| MESH:D002386 | Cataract | Acetaminophen | 12.82 | 10977129 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 12.82 | 12484553 | |
| MESH:D002386 | Cataract | Simvastatin | 12.82 | 12518039 | |
| MESH:D002386 | Cataract | Tretinoin | 12.82 | 17460283 | |
| MESH:D002386 | Cataract | Trinitrotoluene | 12.82 | 15817613 14694615 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 29.13 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 29.13 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 29.13 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 29.13 | 1399818 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 29.13 | 21159647 2727394 7505956 17174075 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 29.13 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 29.13 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 29.13 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 29.13 | 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 29.13 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 29.13 | 19524636 20056578 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 3.98 | 4080065 | |
| MESH:D002524 | Cerebellar Ataxia | Antimony Sodium Gluconate | 5.25 | 16432602 | |
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.52 | 19095969 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 3.24 | 16129372 | |
| MESH:D015362 | Child Nutrition Disorders | Vitamin A | 4.12 | 16153327 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 9.20 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 9.20 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 9.20 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.81 | 11181007 | |
| MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 10.20 | 19486331 9022650 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 10.20 | 11677210 17681005 16919318 17333356 16105132 15861022 17110522 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 10.20 | 19176532 | |
| MESH:D002779 | Cholestasis | Vitamin A | 10.20 | 16175620 | |
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.52 | 11748493 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.79 | 16461808 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 5.00 | 21254359 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 5.00 | 2227380 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 9.86 | 21254359 8946559 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 9.86 | 6856622 3877104 6862529 1687470 2227380 10789828 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 9.86 | 8697196 12621046 16354765 15340226 15668235 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 9.86 | 9407595 | |
| MESH:D002972 | Cleft Palate | Vitamin A | 9.86 | 16054864 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.30 | 15800139 | |
| MESH:D003092 | Colitis | Amiloride | 25.14 | 12065299 | |
| MESH:D003092 | Colitis | Curcumin | 25.14 | 18200517 16804969 16782535 | |
| MESH:D003092 | Colitis | resveratrol | 25.14 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 25.14 | 17936198 | |
| MESH:D003092 | Colitis | tcdA protein, Clostridium difficile | 25.14 | 16920976 | |
| MESH:D003092 | Colitis | Tretinoin | 25.14 | 17035595 | |
| MESH:D003092 | Colitis | Trinitrobenzenesulfonic Acid | 25.14 | 18023891 16474422 17991707 18200517 16867261 16804969 17936198 16782535 11698051 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 4.04 | 20423518 | |
| MESH:D003093 | Colitis, Ulcerative | Trinitrobenzenesulfonic Acid | 4.04 | 17276891 | |
| MESH:D003103 | Coloboma | Curcumin | 7.18 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 7.18 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 23.02 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 23.02 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 23.02 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 23.02 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 23.02 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 23.02 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 23.02 | 15936596 15786552 11260862 15963497 15625704 15637740 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 23.02 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 23.02 | 19440933 15741050 11134977 19056647 17148506 16640504 17191121 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 23.02 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | rofecoxib | 23.02 | 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Vitamin A | 23.02 | 17219422 16267017 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 23.02 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 9.86 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 9.86 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 9.86 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 9.86 | 11197048 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 9.86 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 9.86 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 9.86 | 17245555 16963246 17087956 16985020 17116713 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 9.86 | 11197048 17054584 18059344 12606626 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 9.86 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 9.86 | 16550006 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 8.77 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 8.77 | 14669216 17141729 | |
| MESH:D000013 | Congenital Abnormalities | Trinitrotoluene | 8.77 | 15095906 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.57 | 18497527 | |
| MESH:D003324 | Coronary Artery Disease | marker/mechanism | |||
| MESH:D003324 | Coronary Artery Disease | Homocysteine | 4.29 | 16379339 | |
| MESH:D003324 | Coronary Artery Disease | valsartan | 4.29 | 17719468 | |
| MESH:D003327 | Coronary Disease | Fructose | 5.33 | 18504504 | |
| MESH:D003327 | Coronary Disease | resveratrol | 5.33 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.89 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.35 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 7.42 | 10350223 | |
| MESH:D003371 | Cough | Enalapril | 7.42 | 11725383 | |
| MESH:D003384 | Coxsackievirus Infections | valsartan | 4.50 | 20392896 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 12.89 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 12.89 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 12.89 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 12.89 | 9879862 18769834 | |
| MESH:D019465 | Craniofacial Abnormalities | nitrofen | 12.89 | 11405365 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 12.89 | 19952982 8986270 9212184 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 12.89 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 12.89 | 20055451 15322242 10048152 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 12.89 | 9125849 14991402 8800419 9224671 10589399 9142499 16925845 9664655 17551590 9211117 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin A | 12.89 | 10992263 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 12.89 | 19769572 | |
| MESH:D003394 | Craniofacial Dysostosis | mycophenolate mofetil | 5.86 | 18238994 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.26 | 12952375 16002989 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.49 | 16547730 | |
| MESH:D003490 | Cyanosis | Trinitrotoluene | 3.61 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 10.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 10.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Hydroxychloroquine | 10.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 10.76 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 7.77 | 12161096 | |
| MESH:D003556 | Cystitis | Hydrochloric Acid | 7.77 | 12853844 20719367 12599022 19279288 | |
| MESH:D018856 | Cystitis, Interstitial | Hydrochloric Acid | 4.45 | 17714534 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.83 | 15213294 | |
| MESH:D003665 | Decompression Sickness | zileuton | 4.86 | 18309904 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.04 | 19031437 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 2.97 | 17474826 | |
| MESH:D003872 | Dermatitis | 3-xylene | 7.50 | 12717741 15902427 | |
| MESH:D003872 | Dermatitis | Benzene | 7.50 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 6.40 | 12868966 11298694 11906362 8970840 8156756 2524372 18759878 14531868 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 6.40 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 6.40 | 16823706 11298694 16780908 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 6.40 | 18759878 15491423 12956900 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.61 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 5.43 | 3621924 2952479 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 5.43 | 17010967 | |
| MESH:D002658 | Developmental Disabilities | Choline | 3.64 | 16818868 | |
| MESH:D048909 | Diabetes Complications | Glycosylation End Products, Advanced | 5.27 | 19471234 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 8.79 | 16604332 16640825 | |
| MESH:D003920 | Diabetes Mellitus | rosiglitazone | 8.79 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 8.79 | 16285004 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Fructose | 21.24 | 18603373 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 21.24 | 19028559 12093613 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 21.24 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 21.24 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 21.24 | 17442507 2177838 16684804 16286809 1374869 19496084 7637645 15862027 19960420 18603373 12446591 11260395 12093613 19298542 11055810 12083368 15298345 8740154 17874149 19586609 15831366 12644472 6379147 18715473 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | valsartan | 21.24 | 11508273 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | vanadyl sulfate | 21.24 | 16684804 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 7.10 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 7.10 | 18603373 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Uric Acid | 7.10 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Vitamin A | 7.10 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 24.78 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 24.78 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 24.78 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 24.78 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Fructose | 24.78 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 24.78 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 24.78 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 24.78 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 24.78 | 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 24.78 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 24.78 | 17107852 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 24.78 | 16023994 | |
| MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.32 | 12601628 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.38 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 28.64 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 28.64 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 28.64 | 19706694 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 28.64 | 17451421 17308373 15920148 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 28.64 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 28.64 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 28.64 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | valsartan | 28.64 | 18630688 11427623 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.17 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 4.13 | 17662242 | |
| MESH:D003967 | Diarrhea | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 14.75 | 10611417 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 14.75 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 14.75 | 7237001 10446763 11488427 | |
| MESH:D003967 | Diarrhea | Endotoxins | 14.75 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Indomethacin | 14.75 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | tcdA protein, Clostridium difficile | 14.75 | 16920976 | |
| MESH:D004283 | Dog Diseases | Allopurinol | 4.92 | 10449224 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 4.07 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 4.18 | 15024534 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 29.37 | 6679447 9022650 9328219 6482804 7440962 9653073 18692083 18648102 8291058 18289764 16192314 11289319 1440618 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 29.37 | 15619225 16393943 12153990 12392966 10663392 16781746 2444490 17562736 19923254 16081117 18713872 14725611 10774834 16485898 19420014 12705907 12594235 19085960 19164858 12958197 11461765 19370779 19739265 17522070 14550746 11421492 11743745 16227642 12540782 16109766 11529661 14986274 17906064 11834606 10915739 15968718 18071297 16177239 19416960 11287661 11739529 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 29.37 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Amiodarone | 29.37 | 18218290 15265979 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 29.37 | 7440962 6623471 3786805 15998439 19336974 6884620 4309450 10092053 17522070 7179309 7120509 15027814 3732212 11566570 16227642 21278145 9327722 2869522 16177239 15968718 19085960 10915739 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 29.37 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 29.37 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 29.37 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Halothane | 29.37 | 12919722 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ritonavir | 29.37 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 29.37 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 29.37 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 29.37 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Trinitrotoluene | 29.37 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 29.37 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 29.37 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.73 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 21.76 | 19839026 12649298 15033597 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 21.76 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 21.76 | 15033597 11033412 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 21.76 | 12231392 12649298 | |
| MESH:D004362 | Drug Toxicity | Stavudine | 21.76 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 21.76 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 21.76 | 15040536 | |
| MESH:D015352 | Dry Eye Syndromes | Vitamin A | 4.45 | 16146918 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 8.78 | 18450898 18446180 16133044 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 8.78 | 18043480 16326151 18446180 17190690 12774134 16133044 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 8.16 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 8.16 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 8.16 | 17151854 17202747 17045617 11595431 11535926 17351913 16699067 10671773 11595415 17329845 11991626 | |
| MESH:D050171 | Dyslipidemias | Clofibrate | 5.52 | 16707586 | |
| MESH:D050171 | Dyslipidemias | Fenofibrate | 5.52 | 16707586 | |
| MESH:D004417 | Dyspnea | Budesonide | 6.57 | 20016425 | |
| MESH:D004417 | Dyspnea | Oxygen | 6.57 | 20016425 | |
| MESH:C538011 | Eales disease | Vitamin A | 8.61 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 8.61 | 9068938 | |
| MESH:D004480 | Ectromelia | Vitamin A | 4.46 | 16054864 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.17 | 12438553 | |
| MESH:D004487 | Edema | Aspirin | 44.87 | 17259670 | |
| MESH:D004487 | Edema | Bleomycin | 44.87 | 17118201 | |
| MESH:D004487 | Edema | Carrageenan | 44.87 | 17259670 8985016 12787963 12798668 18841975 12083418 18449507 15860553 18621150 10653021 16100529 | |
| MESH:D004487 | Edema | Cimetidine | 44.87 | 19703484 | |
| MESH:D004487 | Edema | Dexamethasone | 44.87 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 44.87 | 19703484 16100529 10653021 7907874 7990266 8985016 8273558 | |
| MESH:D004487 | Edema | Mustard Gas | 44.87 | 11402378 9260866 11428647 11428631 | |
| MESH:D004487 | Edema | pirinixic acid | 44.87 | 12083418 | |
| MESH:D004487 | Edema | Raloxifene | 44.87 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 44.87 | 8985016 | |
| MESH:D004487 | Edema | rosiglitazone | 44.87 | 12083418 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 44.87 | 11000095 12711302 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 44.87 | 9599246 16716910 8113982 11698051 7812673 8273558 15177302 | |
| MESH:D004487 | Edema | verlukast | 44.87 | 17118201 | |
| MESH:D004487 | Edema | zileuton | 44.87 | 9831321 19703484 11698051 17118201 7990266 8273558 7812673 | |
| MESH:D004487 | Edema | Zymosan | 44.87 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 7.44 | 18230668 16714409 15322242 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 7.44 | 18230668 | |
| MESH:D004660 | Encephalitis | 2-arachidonylglycerol | 5.58 | 16364651 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 28.26 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 2,2-bis(4-glycidyloxyphenyl)propane | 28.26 | 16091293 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 28.26 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 28.26 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 28.26 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 28.26 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 28.26 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 28.26 | 19031437 | |
| MESH:D018159 | Endolymphatic Hydrops | Dimethyl Sulfoxide | 5.19 | 20641076 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 7.45 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.45 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 23.03 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 23.03 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 23.03 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 23.03 | 16569247 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 23.03 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 23.03 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 23.03 | 20544844 17893378 19155303 16202921 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 23.03 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 20.11 | 15652904 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 20.11 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 20.11 | 15652904 | |
| MESH:D004715 | Endometriosis | Progesterone | 20.11 | 16134523 | |
| MESH:D004715 | Endometriosis | rofecoxib | 20.11 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 20.11 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 3.79 | 18037988 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 23.88 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 23.88 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 23.88 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 23.88 | 15328337 17637181 15821434 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 23.88 | 12954792 | |
| MESH:D019446 | Endotoxemia | zileuton | 23.88 | 15328337 | |
| MESH:D004751 | Enteritis | Clonidine | 7.56 | 8982514 | |
| MESH:D004751 | Enteritis | Indomethacin | 7.56 | 10567023 17763956 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.00 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.00 | 17923197 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 14.11 | 11298111 | |
| MESH:D004802 | Eosinophilia | montelukast | 14.11 | 10335014 | |
| MESH:D004802 | Eosinophilia | Ovalbumin | 14.11 | 12689652 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 14.11 | 8156442 | |
| MESH:D004802 | Eosinophilia | zileuton | 14.11 | 10764316 8621850 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 3.91 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.86 | 1399206 6251365 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 3.59 | 11558140 17116037 | |
| MESH:D004827 | Epilepsy | Phenytoin | 3.09 | 821787 20417680 11434505 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 3.98 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 3.74 | 3659116 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.81 | 9357497 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.75 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 9.05 | 19566590 | |
| MESH:D004935 | Esophageal Diseases | Hydrochloric Acid | 9.05 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 13.89 | 3581430 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 13.89 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 13.89 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 13.89 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 13.89 | 16481741 15173087 16785472 15464296 17638652 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 13.89 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 13.89 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 13.89 | 16704527 15264214 15150132 15547733 15878914 15623463 16805852 16510608 15547721 | |
| MESH:D004941 | Esophagitis | Hydrochloric Acid | 4.65 | 12928072 | |
| MESH:D004942 | Esophagitis, Peptic | Hydrochloric Acid | 4.65 | 14621274 11346197 20516732 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 8.94 | 16504073 | |
| MESH:D017889 | Exfoliation Syndrome | Homocysteine | 8.94 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 5.10 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 5.10 | 16938888 9664655 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.40 | 18447907 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.35 | 16456712 | |
| MESH:D005234 | Fatty Liver | Amiodarone | 75.28 | 14986274 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 75.28 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 75.28 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 75.28 | 19224547 16045604 61145 15959796 16239168 12795759 17595544 12631006 | |
| MESH:D005234 | Fatty Liver | Clofibrate | 75.28 | 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 75.28 | 19297423 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 75.28 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Endotoxins | 75.28 | 18641190 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 75.28 | 15345470 | |
| MESH:D005234 | Fatty Liver | Fish Oils | 75.28 | 18620774 | |
| MESH:D005234 | Fatty Liver | Fructose | 75.28 | 18395287 19196556 18641190 | |
| MESH:D005234 | Fatty Liver | Iron | 75.28 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 75.28 | 15975614 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 75.28 | 12795759 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 75.28 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 75.28 | 17473493 | |
| MESH:D005234 | Fatty Liver | rosiglitazone | 75.28 | 19196556 | |
| MESH:D005234 | Fatty Liver | Stavudine | 75.28 | 18299183 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 75.28 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 75.28 | 18299183 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.85 | 15751030 16513791 16534752 16611131 16002989 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.85 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.48 | 16234978 | |
| MESH:D005313 | Fetal Death | Phenytoin | 6.39 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 6.39 | 11858732 | |
| MESH:D005315 | Fetal Diseases | mycophenolate mofetil | 5.86 | 18238994 | |
| MESH:D005327 | Fetal Resorption | Vitamin A | 4.01 | 16054864 | |
| MESH:D005334 | Fever | Dinoprostone | 15.67 | 11852909 16997862 | |
| MESH:D005334 | Fever | Ibuprofen | 15.67 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 15.67 | 17627676 11852909 10431976 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 15.67 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 15.67 | 11852909 9205823 | |
| MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 3.65 | 6705139 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.18 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 7.01 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 7.01 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Carrageenan | 18.36 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 18.36 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 18.36 | 14633661 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 18.36 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 39.78 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 39.78 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 39.78 | 18705752 | |
| MESH:D005355 | Fibrosis | Fructose | 39.78 | 18504504 | |
| MESH:D005355 | Fibrosis | Hydrochloric Acid | 39.78 | 18497604 | |
| MESH:D005355 | Fibrosis | Indomethacin | 39.78 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 39.78 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 39.78 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 39.78 | 17994277 | |
| MESH:D005355 | Fibrosis | Trinitrobenzenesulfonic Acid | 39.78 | 17994277 | |
| MESH:D005355 | Fibrosis | valsartan | 39.78 | 16893502 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.81 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.19 | 6392382 | |
| MESH:D005596 | Fractures, Closed | montelukast | 8.78 | 19544365 | |
| MESH:D005596 | Fractures, Closed | zileuton | 8.78 | 19544365 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 4.10 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.97 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 12.23 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Hydrochloric Acid | 12.23 | 12378975 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 12.23 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 11.33 | 16983495 | |
| MESH:D005756 | Gastritis | Folic Acid | 11.33 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 11.33 | 15046732 | |
| MESH:D005764 | Gastroesophageal Reflux | Hydrochloric Acid | 4.03 | 20616304 19957777 12212954 20545468 20516732 19951613 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.38 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.36 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.36 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 4.32 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.86 | 16390469 14659971 | |
| MESH:D005901 | Glaucoma | Folic Acid | 7.63 | 16504073 | |
| MESH:D005901 | Glaucoma | Homocysteine | 7.63 | 16504073 | |
| MESH:D005909 | Glioblastoma | Aspirin | 24.84 | 12870263 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 24.84 | 18405923 | |
| MESH:D005909 | Glioblastoma | Carmustine | 24.84 | 16187019 | |
| MESH:D005909 | Glioblastoma | Curcumin | 24.84 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 24.84 | 17150277 | |
| MESH:D005909 | Glioblastoma | Genistein | 24.84 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 24.84 | 12870263 | |
| MESH:D005909 | Glioblastoma | Quercetin | 24.84 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 24.84 | 17312396 | |
| MESH:D005910 | Glioma | Indomethacin | 5.45 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 5.45 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 5.45 | 17643826 | |
| MESH:D005911 | Gliosis | Paraquat | 3.80 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.86 | 16524712 15173396 | |
| MESH:D015432 | Glomerulonephritis, Membranoproliferative | valsartan | 4.24 | 16928621 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.13 | 11849393 | |
| MESH:D018149 | Glucose Intolerance | Fructose | 4.05 | 19165636 | |
| MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 2.76 | 7505956 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.22 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.00 | 11248219 | |
| MESH:D006130 | Growth Disorders | Amiloride | 3.73 | 19703807 | |
| MESH:D006261 | Headache | Aspirin | 3.62 | 15240983 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 13.06 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 13.06 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 13.06 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 13.06 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 13.06 | 16096774 | |
| MESH:D016489 | Head Injuries, Closed | 2-arachidonylglycerol | 5.58 | 16364651 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 13.87 | 19898482 | |
| MESH:D034381 | Hearing Loss | Dimethyl Sulfoxide | 13.87 | 20641076 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 13.87 | 18024279 17868369 19130971 15968427 | |
| MESH:D034381 | Hearing Loss | Styrene | 13.87 | 17420221 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.79 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.23 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 9.05 | 19566590 | |
| MESH:D006356 | Heartburn | Hydrochloric Acid | 9.05 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 21.00 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 21.00 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Homocysteine | 21.00 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | nitrofen | 21.00 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 21.00 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 21.00 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin A | 21.00 | 16080930 10992263 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 21.00 | 16080930 | |
| MESH:D006331 | Heart Diseases | Antimony Sodium Gluconate | 12.50 | 11049798 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 12.50 | 14766674 16144979 12587719 18674790 16879835 16707910 16244371 16330681 18006777 16244372 16495754 17875725 17888722 | |
| MESH:D006331 | Heart Diseases | mangiferin | 12.50 | 12093613 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 12.50 | 11110106 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 12.50 | 12093613 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 18.07 | 17481944 | |
| MESH:D006333 | Heart Failure | Enalapril | 18.07 | 10979640 12514674 | |
| MESH:D006333 | Heart Failure | Losartan | 18.07 | 10979640 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 18.07 | 20558911 | |
| MESH:D006333 | Heart Failure | pitavastatin | 18.07 | 15502390 | |
| MESH:D006333 | Heart Failure | Selenium | 18.07 | 17162251 | |
| MESH:D006333 | Heart Failure | valsartan | 18.07 | 19027736 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 2.69 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 6.87 | 16183116 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 6.87 | 12579204 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.39 | 16574947 16640825 17053826 16604332 17236123 17255318 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.16 | 16366002 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.10 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.86 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 6.79 | 15633222 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 6.79 | 17276928 18665440 15929193 | |
| MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 12.03 | 6705139 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 12.03 | 19900420 19110552 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 12.03 | 16456712 | |
| MESH:D006505 | Hepatitis | Zymosan | 12.03 | 19110552 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.39 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 3.93 | 17338147 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 4.11 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 11.31 | 19888908 17276780 17182432 17109627 16607473 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 11.31 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | tetrathiomolybdate | 11.31 | 17276780 | |
| MESH:D006529 | Hepatomegaly | Amiodarone | 17.26 | 15265979 | |
| MESH:D006529 | Hepatomegaly | Iron | 17.26 | 16890145 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 17.26 | 19772884 19176532 16221962 18467677 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 17.26 | 16120746 12621046 15340226 | |
| MESH:D006529 | Hepatomegaly | Trinitrotoluene | 17.26 | 15817613 | |
| MESH:D006529 | Hepatomegaly | zileuton | 17.26 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.71 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 7.53 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | nitrofen | 7.53 | 9698600 15793718 17245593 10898222 18280292 11685700 15136996 12746050 18958481 10370017 12904592 9476886 12759764 8863223 15088113 17270546 7520565 18280291 10898224 12194112 16720372 15707848 11409163 9575882 12505043 7760232 11076806 9859898 16490937 11584395 15756563 16080930 9473106 11588001 12407540 11057544 15185205 10646786 16473863 15578192 10359170 11051153 17618886 15764645 10370016 16863852 12547725 10693666 11329586 7576705 10541330 12021965 16292651 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin A | 7.53 | 16863852 17436238 15707848 16292552 16877224 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 7.53 | 16863852 16490937 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.66 | 15709030 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 5.88 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 5.88 | 16876885 | |
| MESH:D015658 | HIV Infections | Indinavir | 19.55 | 11141242 15388451 11363243 | |
| MESH:D015658 | HIV Infections | Iron | 19.55 | 16597321 | |
| MESH:D015658 | HIV Infections | lopinavir | 19.55 | 17378895 | |
| MESH:D015658 | HIV Infections | Nelfinavir | 19.55 | 15388451 11362904 | |
| MESH:D015658 | HIV Infections | Ritonavir | 19.55 | 11363243 15388451 11141242 17378895 | |
| MESH:D015658 | HIV Infections | Stavudine | 19.55 | 11141242 | |
| MESH:D015658 | HIV Infections | Vitamin A | 19.55 | 16960176 | |
| MESH:D015658 | HIV Infections | Zidovudine | 19.55 | 11698656 11363243 20032539 17358032 11141242 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 8.90 | 17209195 | |
| MESH:D006679 | HIV Seropositivity | Vitamin A | 8.90 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Bleomycin | 8.02 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 8.02 | 16170182 16200630 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 8.02 | 17606976 18501091 15147373 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 8.02 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 5.59 | 17088409 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 5.59 | 14716179 | |
| OMIM:609423 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO | marker/mechanism | |||
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.68 | 8697196 16959395 15340226 16354765 18606429 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.40 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 23.21 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 23.21 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 23.21 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Freund's Adjuvant | 23.21 | 16769263 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 23.21 | 12727271 | |
| MESH:D006930 | Hyperalgesia | rosiglitazone | 23.21 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 23.21 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 23.21 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.35 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.19 | 16899240 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 3.80 | 18089816 19622757 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 4.36 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | Amiodarone | 11.85 | 9751232 8137927 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 11.85 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Pravastatin | 11.85 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 11.85 | 17188708 | |
| MESH:D006940 | Hyperemia | Hydrochloric Acid | 8.29 | 12646421 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.29 | 12524144 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.24 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 12.57 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 12.57 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 12.57 | 18262572 11834736 | |
| MESH:D006943 | Hyperglycemia | triphenyltin | 12.57 | 10522495 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 16.28 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 16.28 | 16397167 16395265 16433478 16865747 16755160 | |
| MESH:D020138 | Hyperhomocysteinemia | Homocysteine | 16.28 | 17292331 17369066 18234410 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 16.28 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Superoxides | 16.28 | 12615666 | |
| MESH:D006946 | Hyperinsulinism | Fructose | 6.57 | 15752949 19008412 18360027 18563319 14757778 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 6.57 | 9881663 11315760 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.23 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Fish Oils | 15.70 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Fructose | 15.70 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 15.70 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 15.70 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 15.70 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 4.07 | 16238680 | |
| MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 6.48 | 15034207 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 6.48 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 11.02 | 17604070 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 11.02 | 16536907 | |
| MESH:D006967 | Hypersensitivity | phthalic anhydride | 11.02 | 7930309 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 11.02 | 11019492 10880147 | |
| MESH:D006968 | Hypersensitivity, Delayed | Fish Oils | 4.15 | 11484837 | |
| MESH:D006973 | Hypertension | Amiloride | 31.03 | 15174897 19344079 18524855 | |
| MESH:D006973 | Hypertension | Arsenic | 31.03 | 11953799 16076760 9931084 | |
| MESH:D006973 | Hypertension | Benzene | 31.03 | 17940673 | |
| MESH:D006973 | Hypertension | Dexamethasone | 31.03 | 17042910 | |
| MESH:D006973 | Hypertension | Enalapril | 31.03 | 12717102 10903974 | |
| MESH:D006973 | Hypertension | Fructose | 31.03 | 19008412 14573337 14568997 16843071 14633139 | |
| MESH:D006973 | Hypertension | Losartan | 31.03 | 12586211 15969258 10090350 14597852 12512695 | |
| MESH:D006973 | Hypertension | Ouabain | 31.03 | 18976649 | |
| MESH:D006973 | Hypertension | Phenylephrine | 31.03 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 31.03 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 31.03 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 31.03 | 18850075 18670907 | |
| MESH:D006973 | Hypertension | valsartan | 31.03 | 18344623 12850387 20102058 10903974 12692753 18390891 11427623 16475468 | |
| MESH:D006974 | Hypertension, Malignant | valsartan | 5.04 | 11560862 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 7.05 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | Hydrochloric Acid | 7.05 | 16984587 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Clonidine | 4.85 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | marker/mechanism | 15302794 | ||
| MESH:D006976 | Hypertension, Pulmonary | Epoprostenol | 7.64 | 15302794 | |
| MESH:D006976 | Hypertension, Pulmonary | Hydrochloric Acid | 7.64 | 19262391 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 7.64 | 14726295 | |
| MESH:D015228 | Hypertriglyceridemia | Fructose | 7.34 | 19342510 19799862 | |
| MESH:D015228 | Hypertriglyceridemia | triphenyltin | 7.34 | 10522495 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 6.78 | 16672835 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 6.78 | 12791704 18502941 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 6.72 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 6.72 | 17488730 | |
| MESH:D006986 | Hypervitaminosis A | Vitamin A | 4.80 | 16054864 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.19 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.82 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 3.32 | 16640825 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.51 | 19822448 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.88 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.88 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Hydrochloric Acid | 5.77 | 11574821 | |
| MESH:D007022 | Hypotension | Isoflurane | 5.77 | 12967683 | |
| MESH:D007037 | Hypothyroidism | Amiodarone | 7.32 | 18020914 17991464 | |
| MESH:D007037 | Hypothyroidism | Iron | 7.32 | 16640825 | |
| MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 8.21 | 18306037 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 8.21 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.00 | 10647630 16133968 10651667 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 4.49 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 9.68 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 9.68 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 11.97 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 11.97 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 11.97 | 19309543 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 7.07 | 15036965 | |
| MESH:D007246 | Infertility | triphenyltin | 7.07 | 15205045 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.20 | 12013081 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 15.98 | 17937319 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 15.98 | 11514358 | |
| MESH:D007248 | Infertility, Male | Gossypol | 15.98 | 11202417 9639145 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 15.98 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 15.98 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 15.98 | 15346721 12646999 | |
| MESH:D007248 | Infertility, Male | Trinitrotoluene | 15.98 | 12150543 | |
| MESH:D007249 | Inflammation | Amiloride | 76.67 | 17237260 | |
| MESH:D007249 | Inflammation | Bleomycin | 76.67 | 17118201 | |
| MESH:D007249 | Inflammation | Capsaicin | 76.67 | 16956363 | |
| MESH:D007249 | Inflammation | Carrageenan | 76.67 | 19934399 10653021 16100529 18295198 12787963 12428691 12798668 8985016 7907874 | |
| MESH:D007249 | Inflammation | Curcumin | 76.67 | 18403477 16956363 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 76.67 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 76.67 | 18785209 | |
| MESH:D007249 | Inflammation | ethylisopropylamiloride | 76.67 | 17237260 | |
| MESH:D007249 | Inflammation | Fatty Acids, Omega-3 | 76.67 | 17296493 | |
| MESH:D007249 | Inflammation | Freund's Adjuvant | 76.67 | 16793879 | |
| MESH:D007249 | Inflammation | Hydrochloric Acid | 76.67 | 11574821 | |
| MESH:D007249 | Inflammation | Ibuprofen | 76.67 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 76.67 | 3291741 12568917 7812673 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 76.67 | 17255318 9205823 17963957 12878042 17237260 | |
| MESH:D007249 | Inflammation | Losartan | 76.67 | 12586211 | |
| MESH:D007249 | Inflammation | mangiferin | 76.67 | 15222974 | |
| MESH:D007249 | Inflammation | montelukast | 76.67 | 18059327 | |
| MESH:D007249 | Inflammation | Mustard Gas | 76.67 | 9357497 9260866 11428647 11428620 16001271 17524151 11428631 8975870 11402378 | |
| MESH:D007249 | Inflammation | Progesterone | 76.67 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 76.67 | 16366677 | |
| MESH:D007249 | Inflammation | rosiglitazone | 76.67 | 12083418 | |
| MESH:D007249 | Inflammation | Tamoxifen | 76.67 | 19457130 | |
| MESH:D007249 | Inflammation | tcdA protein, Clostridium difficile | 76.67 | 16920976 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 76.67 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 76.67 | 15177302 7812673 7562506 8273558 11698051 | |
| MESH:D007249 | Inflammation | verlukast | 76.67 | 17118201 | |
| MESH:D007249 | Inflammation | zileuton | 76.67 | 18295198 8960868 7812673 18059327 17118201 9831321 8621850 18309904 | |
| MESH:D007249 | Inflammation | Zymosan | 76.67 | 8014878 11289658 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 8.23 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Leukotriene B4 | 8.23 | 11006272 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Trinitrobenzenesulfonic Acid | 8.23 | 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 8.23 | 15339030 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 20.95 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 20.95 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 20.95 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 20.95 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 20.95 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Berberine | 22.79 | 18563319 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 22.79 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Endotoxins | 22.79 | 20353583 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 22.79 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | Fructose | 22.79 | 17133782 14573337 19799862 18563319 14757778 18057795 19342510 18981581 19008412 19586609 14633139 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 22.79 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 22.79 | 16306350 | |
| MESH:D007333 | Insulin Resistance | rosiglitazone | 22.79 | 16306350 | |
| MESH:D007410 | Intestinal Diseases | Hydrochloric Acid | 21.50 | 11574821 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 21.50 | 17329856 18236018 15831440 10210152 11713966 15610444 11686837 11855677 17994277 | |
| MESH:D007410 | Intestinal Diseases | rofecoxib | 21.50 | 15831440 | |
| MESH:D007410 | Intestinal Diseases | Superoxides | 21.50 | 10210152 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 21.50 | 17994277 | |
| MESH:D007410 | Intestinal Diseases | Trinitrobenzenesulfonic Acid | 21.50 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 6.05 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 6.05 | 10783313 | |
| MESH:D007417 | Intestinal Polyps | rofecoxib | 4.10 | 11245490 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 6.69 | 19381132 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 6.69 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 9.67 | 15241188 | |
| MESH:D019586 | Intracranial Hypertension | Vitamin A | 9.67 | 15955940 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 7.37 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 7.37 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.49 | 17553498 | |
| MESH:D007511 | Ischemia | mangiferin | 7.22 | 16806951 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 7.22 | 16301206 | |
| MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 3.65 | 9022650 8074119 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 5.80 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 5.80 | 17551590 15992940 | |
| MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 8.21 | 18306037 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 8.21 | 16133968 18306037 10574470 | |
| MESH:D007627 | Keloid | Quercetin | 3.63 | 17086741 | |
| MESH:D007642 | Keratosis | Arsenic | 3.64 | 16930632 12749816 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 8.81 | 15464296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 8.81 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 44.31 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 44.31 | 12488133 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 44.31 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 44.31 | 12231392 19839026 15190930 12649298 18289764 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 44.31 | 15699352 16775033 15369732 | |
| MESH:D007674 | Kidney Diseases | Enalapril | 44.31 | 10903974 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 44.31 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 44.31 | 18289764 17934191 19349640 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 44.31 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 44.31 | 12093613 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 44.31 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 44.31 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 44.31 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 44.31 | 12093613 | |
| MESH:D007674 | Kidney Diseases | valsartan | 44.31 | 16893502 12164870 10903974 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 44.31 | 12488133 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 13.76 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 13.76 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 13.76 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 13.76 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 11.23 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 11.23 | 15003126 14681315 16762066 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 11.23 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 11.23 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 11.23 | 12579204 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 12.04 | 16316344 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 12.04 | 11231351 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 12.04 | 11231351 | |
| MESH:D007818 | Laryngeal Diseases | Hydrochloric Acid | 4.99 | 16498863 | |
| MESH:D007826 | Laryngismus | Hydrochloric Acid | 4.99 | 11510729 | |
| MESH:D007859 | Learning Disorders | Copper | 12.40 | 17134702 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 12.40 | 17184923 | |
| MESH:D007859 | Learning Disorders | mangiferin | 12.40 | 19182383 | |
| MESH:D007859 | Learning Disorders | sevoflurane | 12.40 | 19212262 | |
| MESH:D007889 | Leiomyoma | Curcumin | 6.94 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 6.94 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Antimony Sodium Gluconate | 4.13 | 7960131 20139272 8059918 7945751 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | marker/mechanism | 20102417 | ||
| MESH:D016773 | Leishmaniasis, Cutaneous | Allopurinol | 10.51 | 12207774 9314461 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony Sodium Gluconate | 10.51 | 7724530 1323630 7570843 8407083 11528583 10617787 15610669 9499605 10886148 15234329 1311351 10542306 10233236 9299828 1322070 2166429 1314873 9234779 1329273 9770149 14512915 9314461 19744259 7682386 10786029 15259478 17278657 2160914 15678803 20438389 12032913 10647737 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 10.51 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 10.51 | 10320625 12228301 11703811 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony Sodium Gluconate | 4.64 | 2173461 7519887 1322070 1645930 16135192 1325634 | |
| MESH:D007898 | Leishmaniasis, Visceral | Allopurinol | 5.43 | 11332679 7498017 10449224 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony Sodium Gluconate | 5.43 | 16131481 2098410 7983993 11417033 9498473 9665985 10617787 12870129 17382981 7903366 8607595 17300636 16432602 15518175 20576500 7932924 17911647 11035738 10805470 15716043 1315397 12379707 1852133 12803856 12898450 10604050 9844051 8394861 9531339 15610669 7498017 15868188 10952587 1319700 12955641 7844400 10603400 8916804 15896700 10569788 11398119 9856145 18765878 7715298 1314709 1315396 10886148 1658990 9625910 12718341 16117959 1645929 15328135 11049798 1659303 9756784 1337639 10467834 11751149 11069076 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 19.16 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 19.16 | 15070760 | |
| MESH:D007938 | Leukemia | Benzene | 19.16 | 14694614 17119257 18335105 15935818 | |
| MESH:D007938 | Leukemia | Curcumin | 19.16 | 18462866 | |
| MESH:D007938 | Leukemia | Genistein | 19.16 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | kaempferol | 19.16 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 19.16 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 19.16 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 9.71 | 16085563 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 9.71 | 16085563 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 21.93 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 21.93 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 21.93 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Ritonavir | 21.93 | 16174765 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 21.93 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 21.93 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 17.26 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 17.26 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 17.26 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 17.26 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic disulfide | 14.55 | 12421474 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 14.55 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 14.55 | 10785260 16572323 15631656 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 14.55 | 15498116 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 14.55 | 19823023 19503090 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 8.90 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 8.90 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 8.90 | 19285840 16932348 16482212 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 4.57 | 19850784 16467208 16968895 20471514 17050201 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 4.57 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 4.57 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.57 | 16294345 19850784 17596541 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 12.88 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 12.88 | 12679006 12018890 16823087 17869043 16891316 15622746 17649720 17217047 16966277 19642359 19225113 17712046 11161223 15336539 15213294 12712474 17107899 16112521 19075265 9834237 16330433 11468182 15748426 16331271 19035177 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 12.88 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 12.88 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 12.88 | 17712046 19225113 19642359 16788101 9834237 17506722 17217047 19075265 17339181 19029980 17107899 12679006 16823087 17361223 16140955 17368321 16891316 16935935 19035177 17301526 17649720 16331271 17294898 15748426 16766008 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.41 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.41 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.00 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.35 | 17980183 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.36 | 15821434 | |
| MESH:D020961 | Lewy Body Disease | Iron | 4.10 | 16563566 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.65 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 7.55 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 7.55 | 9224671 | |
| MESH:D017880 | Limb Deformities, Congenital | Vitamin A | 7.55 | 16054864 | |
| MESH:D008064 | Lipidoses | Amiodarone | 4.31 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 4.31 | 17567588 15342952 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.35 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 16.80 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 16.80 | 17174718 16943688 17334410 16221502 16239168 11408273 17157831 21278145 11903743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 16.80 | 20032147 18407596 18665156 19638242 18522880 | |
| MESH:D008103 | Liver Cirrhosis | Endotoxins | 16.80 | 20353583 | |
| MESH:D008103 | Liver Cirrhosis | Hydrochloric Acid | 16.80 | 16984587 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 16.80 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Vitamin A | 16.80 | 16256175 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 2.19 | 9327722 15034207 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 15492853 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | 1,3-dimethylthiourea | 52.02 | 11682029 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 52.02 | 15876570 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 52.02 | 17805973 12609069 17761835 17944888 14748882 15925388 16638106 18054572 17922224 18395095 18210741 18006644 15931870 18705752 16248980 10355542 15730626 17525996 18395914 14620537 15673190 16027843 18472094 18429990 18277467 18263696 12632514 15057751 12649538 15893842 17481882 14716496 17708605 14716833 15338365 16116963 17869086 11481614 18472332 13678700 16136751 14724832 16192424 18156304 17714472 16033810 17631135 17721639 12632512 12445418 15362042 16097048 15818738 18420326 18412020 17900296 12741479 18279442 12546737 15370692 18376398 14512876 12445421 12667390 18251166 15959796 18339082 18166357 15996030 18205269 18418968 17565644 12586293 17976157 12958196 15052691 15123356 15650968 15876570 16015684 17557913 16011737 12898905 12389079 17640975 20821823 17766677 17698563 18187930 12666154 17823541 18317297 18481824 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 52.02 | 17355460 18006644 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 52.02 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 52.02 | 16009107 15138612 14568256 15161499 15369754 15504291 17465448 15577212 14726149 14659978 17201889 17881167 15571005 17196135 15383259 15591649 17724770 16169303 15479170 18210741 14643895 15298665 17198567 15723089 15492853 18629640 17666798 18637143 15864749 12925901 15086199 16570917 12918455 15798949 15842777 18239293 15942678 18567088 15067225 17203207 15733078 16603200 15099470 16627068 18371158 15744066 15366600 16544323 17719030 15793283 18095165 17534399 17348192 18672772 18364076 15081153 18237412 17432682 15763062 14709902 15339415 16270385 16042886 17036385 17640959 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethyl Sulfoxide | 52.02 | 11682029 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 52.02 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 52.02 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Enalapril | 52.02 | 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 52.02 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 52.02 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 52.02 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Heparin | 52.02 | 16904936 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 52.02 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 52.02 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Losartan | 52.02 | 12445418 17900296 15573910 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 52.02 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 52.02 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 52.02 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rofecoxib | 52.02 | 17565644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 52.02 | 17347453 15980055 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 52.02 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 52.02 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 52.02 | 15078482 15474484 18606216 11682029 10677585 18295389 12679928 17629604 15288473 18458672 17127702 16126171 16489207 18380797 18032466 16248980 18416461 15716488 15075984 17292413 12085344 18031379 11172339 15095483 12557150 15158331 16511523 15465738 15334695 17355460 15316131 15362042 12531686 12891558 18263696 16343077 16097051 12175628 17050028 15288472 18615449 16098781 18395095 14739098 11481614 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 52.02 | 18397230 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | valsartan | 52.02 | 15619341 15504291 16872305 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin A | 52.02 | 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 52.02 | 16169303 | |
| MESH:D008107 | Liver Diseases | marker/mechanism | 17125873 | ||
| MESH:D008107 | Liver Diseases | Acetaminophen | 26.95 | 19014921 16611625 12969438 16610002 19460945 12587719 19784758 11587558 | |
| MESH:D008107 | Liver Diseases | Antimony Sodium Gluconate | 26.95 | 7570843 | |
| MESH:D008107 | Liver Diseases | Arsenic | 26.95 | 11134558 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 26.95 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 26.95 | 16964402 15830285 17285989 15720792 16246199 | |
| MESH:D008107 | Liver Diseases | chlorobenzene | 26.95 | 1949037 | |
| MESH:D008107 | Liver Diseases | Curcumin | 26.95 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 26.95 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 26.95 | 15816358 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 26.95 | 17056761 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 26.95 | 16877991 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 26.95 | 14986274 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 26.95 | 15158337 18374380 16337175 | |
| MESH:D008107 | Liver Diseases | Vitamin A | 26.95 | 16175620 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 7.32 | 16737972 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Vitamin A | 7.32 | 16762690 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 7.48 | 15123358 | |
| MESH:D017093 | Liver Failure | Stavudine | 7.48 | 18299183 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 17.77 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 17.77 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 17.77 | 17457977 | |
| MESH:D017114 | Liver Failure, Acute | Epoprostenol | 17.77 | 15633222 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 17.77 | 15633222 17276928 12479984 15313186 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 43.38 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 43.38 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 43.38 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 43.38 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 43.38 | 21295105 19389873 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 43.38 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 43.38 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 43.38 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 43.38 | 21071580 12112319 21167192 19426721 19255062 21278145 20583210 20101389 2862719 19499222 19294768 19638242 19642983 19254457 19551842 18977376 19996281 12771043 9163691 20137499 19850985 15175105 10737359 19690152 21047994 18648771 20492335 19833225 20434301 19256749 16942905 2422723 19073162 20118626 20501860 19812893 15885732 19427195 18754104 18644402 19090486 18978307 20452335 20405173 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 43.38 | 15890375 16712894 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 43.38 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Fenofibrate | 43.38 | 18978307 | |
| MESH:D008113 | Liver Neoplasms | Iron | 43.38 | 16640825 20302851 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 43.38 | 20007298 15890375 16377806 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 43.38 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 43.38 | 20405173 19812893 19073162 19321006 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 43.38 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 43.38 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 43.38 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 31.11 | 6587162 1399818 598648 3712494 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 31.11 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 31.11 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 31.11 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 31.11 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 31.11 | 19519916 19126423 18282651 18164116 16842330 19004024 18308698 3124819 2563599 21159647 9362446 17942915 19009564 18093689 16267830 18544905 19539802 18253720 18775883 18079962 17174075 17854601 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 31.11 | 15603536 1848544 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 31.11 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 31.11 | 18253720 18775883 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 31.11 | 1399818 598648 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 31.11 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 31.11 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vitamin A | 31.11 | 17113696 | |
| MESH:D008133 | Long QT Syndrome | Amiodarone | 4.47 | 15350150 11989578 17391786 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 4.47 | 15213294 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.14 | 16080182 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 34.12 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 34.12 | 11504702 | |
| MESH:D008171 | Lung Diseases | Amiodarone | 34.12 | 12587719 | |
| MESH:D008171 | Lung Diseases | Asbestos, Serpentine | 34.12 | 17200189 | |
| MESH:D008171 | Lung Diseases | Hydrochloric Acid | 34.12 | 16784557 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 34.12 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | nitrofen | 34.12 | 16863852 9859898 17245593 9614859 | |
| MESH:D008171 | Lung Diseases | Ozone | 34.12 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 34.12 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin A | 34.12 | 16863852 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 34.12 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Amiodarone | 6.98 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 6.98 | 14698565 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 18.56 | 17365036 | |
| MESH:D055370 | Lung Injury | Hydrochloric Acid | 18.56 | 19644408 21311175 19262391 15044056 17627322 18573544 15090967 16129981 21114838 18339021 20597076 18497604 15607125 11395602 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 18.56 | 21114838 | |
| MESH:D055370 | Lung Injury | Oxygen | 18.56 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 18.56 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 18.56 | 16129981 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 74.27 | 12438228 16401635 18508827 15172992 15893417 17139156 9255578 19931552 14755239 18813816 16061637 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 74.27 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | Acrylonitrile | 74.27 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 74.27 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 74.27 | 17306315 19168569 17976673 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 74.27 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 74.27 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Asbestos | 74.27 | 12111688 | |
| MESH:D008175 | Lung Neoplasms | Asbestos, Serpentine | 74.27 | 11198217 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 74.27 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 74.27 | 20064080 18816296 17053015 18569708 20869020 20464547 6695378 20135361 18520028 | |
| MESH:D008175 | Lung Neoplasms | Bleomycin | 74.27 | 6189445 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 74.27 | 17163412 12117777 16885199 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 74.27 | 19359593 11246140 15390079 16337739 11696405 18597497 19925653 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 74.27 | 11798837 17225452 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 74.27 | 19359593 18462866 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 74.27 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 74.27 | 21163286 20970405 6695378 20512841 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 74.27 | 16061637 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 74.27 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 74.27 | 11053908 11497255 16537180 | |
| MESH:D008175 | Lung Neoplasms | Iron | 74.27 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 74.27 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 74.27 | 18520028 18816296 18569708 | |
| MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 74.27 | 20512841 1399818 6695378 9230183 17909032 16271038 11893704 20970405 21163286 7750092 16337739 10545420 15390079 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 74.27 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 74.27 | 3148597 8781369 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 74.27 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 74.27 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | Smoke | 74.27 | 11091918 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 74.27 | 15276417 17077188 16712894 17306315 19931552 | |
| MESH:D008175 | Lung Neoplasms | Styrene | 74.27 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 74.27 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 74.27 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 74.27 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 74.27 | 11062179 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 74.27 | 18800350 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 4.25 | 17718048 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | mycophenolate mofetil | 4.25 | 18238994 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.80 | 15166399 | |
| MESH:D008223 | Lymphoma | Benzene | 15.31 | 17584886 17119257 | |
| MESH:D008223 | Lymphoma | cannabidiol hydroxyquinone | 15.31 | 17478614 | |
| MESH:D008223 | Lymphoma | Curcumin | 15.31 | 18462866 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 15.31 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 15.31 | 16098063 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 15.31 | 11418001 16257854 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 6.34 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 6.34 | 17088997 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 5.00 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 5.00 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 12.05 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 12.05 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 12.05 | 15621674 | |
| MESH:D008231 | Lymphopenia | Antimony Sodium Gluconate | 5.05 | 9770149 | |
| MESH:D008268 | Macular Degeneration | Iron | 3.06 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.15 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Acrylonitrile | 17.46 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 17.46 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 17.46 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Styrene | 17.46 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 17.46 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 48.87 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 48.87 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 48.87 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 48.87 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 48.87 | 12807724 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 48.87 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 48.87 | 11807958 16891317 11408345 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 48.87 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 48.87 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 48.87 | 10767621 11751437 15113128 17131329 16619500 10838139 15688392 14999141 14633655 16944150 16051031 16827153 11807958 12931682 17020996 15313902 19196723 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 48.87 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 48.87 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 48.87 | 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | salinomycin | 48.87 | 19682730 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 48.87 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 48.87 | 19196722 14580682 19196723 11731420 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 48.87 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 48.87 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.14 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.14 | 19453300 | |
| MESH:D008382 | Marfan Syndrome | Losartan | 4.75 | 19430350 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.35 | 16832597 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.04 | 17453147 | |
| MESH:D008545 | Melanoma | Bleomycin | 20.02 | 15577320 | |
| MESH:D008545 | Melanoma | Carmustine | 20.02 | 12393984 | |
| MESH:D008545 | Melanoma | Cisplatin | 20.02 | 18332650 18176117 12883367 12374674 17761969 16432458 16248763 12393984 11135225 18505091 17023156 16809738 15577323 | |
| MESH:D008545 | Melanoma | Curcumin | 20.02 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | Doxorubicin | 20.02 | 16827129 | |
| MESH:D008545 | Melanoma | Glucose | 20.02 | 14993021 | |
| MESH:D008545 | Melanoma | Isotretinoin | 20.02 | 17237267 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 20.02 | 16487513 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 20.02 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 20.02 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 20.02 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Tamoxifen | 20.02 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 20.02 | 16752155 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 7.08 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 7.08 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 6.63 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 6.63 | 10803710 | |
| MESH:D008569 | Memory Disorders | Curcumin | 8.84 | 17263510 | |
| MESH:D008569 | Memory Disorders | mangiferin | 8.84 | 19182383 | |
| MESH:D008569 | Memory Disorders | sevoflurane | 8.84 | 19212262 | |
| MESH:D008591 | Meningomyelocele | Homocysteine | 8.04 | 16602021 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 8.04 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.53 | 17109627 17268249 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 3.02 | 9212184 | |
| MESH:D008654 | Mesothelioma | Asbestos | 13.50 | 16919927 18709470 16564556 16319530 18310086 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 13.50 | 16966607 18303189 16166281 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 13.50 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 13.50 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 13.50 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 13.50 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 6.90 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 6.90 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | marker/mechanism | 16188961 18486454 | ||
| MESH:D024821 | Metabolic Syndrome X | Fructose | 6.12 | 17261469 19165636 18497449 17098227 16815490 | |
| MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 6.12 | 17261469 | |
| MESH:D008679 | Metaplasia | Ozone | 3.74 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | Chloroquine | 4.49 | 3537620 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.47 | 17358032 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 6.67 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 6.67 | 11903285 | |
| MESH:D008881 | Migraine Disorders | montelukast | 6.67 | 10759916 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 3.98 | 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.25 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.18 | 15863610 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 4.90 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 4.90 | 12636206 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.45 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | marker/mechanism | 16918137 | ||
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 28.46 | 19417148 19549372 14977855 15949261 11468182 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 28.46 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 28.46 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 28.46 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 28.46 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 28.46 | 15744524 15867202 16118317 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 28.46 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 28.46 | 14749477 16490592 17164350 16267019 17935668 17049120 | |
| MESH:D009101 | Multiple Myeloma | Vitamin A | 28.46 | 16374440 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 28.46 | 18089719 16996129 19621390 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.95 | 15213630 15241586 15259001 10890648 18160304 12879239 15834315 12130978 17724436 10479408 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.31 | 17086897 | |
| MESH:D009128 | Muscle Spasticity | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 4.76 | 17220914 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 7.97 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 7.97 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 2.20 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.91 | 18694830 | |
| MESH:D009164 | Mycobacterium Infections | Indinavir | 10.80 | 21442799 | |
| MESH:D009164 | Mycobacterium Infections | lopinavir | 10.80 | 21442799 | |
| MESH:D009164 | Mycobacterium Infections | Ritonavir | 10.80 | 21442799 | |
| MESH:D009181 | Mycoses | Amiodarone | 8.63 | 17974566 12754197 | |
| MESH:D009181 | Mycoses | Iron | 8.63 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.31 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 6.70 | 16882451 16105982 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 6.70 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 6.70 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 30.64 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 30.64 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 30.64 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 30.64 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Homocysteine | 30.64 | 17412321 | |
| MESH:D009203 | Myocardial Infarction | Hydrochloric Acid | 30.64 | 18534312 | |
| MESH:D009203 | Myocardial Infarction | Losartan | 30.64 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 30.64 | 16697266 17052832 19172585 16538859 16584858 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 30.64 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Pravastatin | 30.64 | 17188708 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 30.64 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 30.64 | 16456233 17188708 17015251 16317513 16525036 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 12.42 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 12.42 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 12.42 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 12.42 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 14.73 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 14.73 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 14.73 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 14.73 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 14.73 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.42 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 4.18 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 4.07 | 1896199 | |
| MESH:D009232 | Myxoma | Raloxifene | 4.18 | 16343187 | |
| MESH:D009298 | Nasal Polyps | zileuton | 4.86 | 10665187 | |
| MESH:D009325 | Nausea | Aspirin | 3.86 | 15240983 | |
| MESH:D009336 | Necrosis | Trinitrotoluene | 3.44 | 18551238 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 10.01 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 10.01 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 10.01 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 14.87 | 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 14.87 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 14.87 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 14.87 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 14.87 | 11239499 11053908 16537180 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 14.87 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 14.87 | 19139120 17312309 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.88 | 19410462 | |
| MESH:D009369 | Neoplasms | Acrolein | 20.47 | 17329238 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 20.47 | 11141357 | |
| MESH:D009369 | Neoplasms | Berberine | 20.47 | 12415430 | |
| MESH:D009369 | Neoplasms | Cisplatin | 20.47 | 16773208 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 20.47 | 15313581 | |
| MESH:D009369 | Neoplasms | Epoprostenol | 20.47 | 17264769 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 20.47 | 15533788 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 20.47 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 20.47 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 20.47 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 20.47 | 16946489 16594593 | |
| MESH:D009374 | Neoplasms, Experimental | Asbestos, Serpentine | 18.85 | 11704859 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 18.85 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 18.85 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 18.85 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 18.85 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 18.85 | 1670384 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 10.64 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 10.64 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 10.64 | 19200415 19196722 19189210 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 17.91 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | cannabidiol hydroxyquinone | 17.91 | 16571653 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 17.91 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 17.91 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | parthenolide | 17.91 | 16921510 | |
| MESH:D009393 | Nephritis | Acrolein | 4.92 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 6.45 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 6.45 | 6375363 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.45 | 16899518 16636307 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 5.77 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 5.77 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 7.78 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 7.78 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 7.78 | 16893418 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 21.94 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 21.94 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 21.94 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 21.94 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 21.94 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 21.94 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.26 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | marker/mechanism | |||
| MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 29.71 | 6679447 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 29.71 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 29.71 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 29.71 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 29.71 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 29.71 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 29.71 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 29.71 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 29.71 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Vitamin A | 29.71 | 17400914 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.14 | 11555667 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 6.26 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 6.26 | 15555623 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 6.26 | 17368321 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 17.86 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 17.86 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 17.86 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 17.86 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 17.86 | 16604332 17296847 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 17.86 | 17652729 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 3.37 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 15.11 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 15.11 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 15.11 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 15.11 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.75 | 20387270 | |
| MESH:D020258 | Neurotoxicity Syndromes | 3-xylene | 3.95 | 8907413 7820390 | |
| MESH:D009503 | Neutropenia | Folic Acid | 15.74 | 16322990 | |
| MESH:D009503 | Neutropenia | Leukotriene B4 | 15.74 | 8305713 | |
| MESH:D009503 | Neutropenia | lopinavir | 15.74 | 17378895 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 15.74 | 16761898 7688884 | |
| MESH:D009503 | Neutropenia | Ritonavir | 15.74 | 17378895 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 3.62 | 9802331 | |
| MESH:C541083 | Non-alcoholic Fatty Liver Disease | Endotoxins | 4.65 | 20353583 | |
| MESH:D009765 | Obesity | Capsaicin | 5.64 | 19056576 | |
| MESH:D009765 | Obesity | Curcumin | 5.64 | 19297423 | |
| MESH:D009765 | Obesity | Fructose | 5.64 | 18585860 17707055 | |
| MESH:D009765 | Obesity | pirinixic acid | 5.64 | 20558911 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.81 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 15.64 | 6482804 4026338 | |
| MESH:D009784 | Occupational Diseases | Benzene | 15.64 | 17178637 15612468 15576619 17119257 17479406 15913788 15935809 15727169 16737584 | |
| MESH:D009784 | Occupational Diseases | Hydrochloric Acid | 15.64 | 12378975 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 15.64 | 12585506 3040596 11077013 8156442 6091946 18394133 6091945 | |
| MESH:D009784 | Occupational Diseases | Trinitrotoluene | 15.64 | 17852074 14694615 12819281 | |
| MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 3.65 | 3988306 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 12.88 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 12.88 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 12.88 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 12.88 | 16640825 | |
| MESH:D010003 | Osteoarthritis | rofecoxib | 12.88 | 16690336 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 5.11 | 18500342 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 4.03 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 4.07 | 17016548 | |
| MESH:D010024 | Osteoporosis | Calcium | 18.06 | 17882678 | |
| MESH:D010024 | Osteoporosis | Curcumin | 18.06 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 18.06 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 18.06 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | kaempferol | 18.06 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 18.06 | 19059307 17882678 15775268 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 18.06 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 13.75 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 13.75 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 13.75 | 15579764 17823083 17893378 15758505 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 13.75 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.95 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.64 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 29.13 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 29.13 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 29.13 | 16624393 12452020 19769630 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 29.13 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 29.13 | 6897625 17225452 19769630 15464296 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 29.13 | 19020741 18462866 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 29.13 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 29.13 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 29.13 | 16525653 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 29.13 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 29.13 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 29.13 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 29.13 | 16211241 | |
| MESH:D010146 | Pain | Acetaminophen | 23.90 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 23.90 | 6995502 6363464 | |
| MESH:D010146 | Pain | Capsaicin | 23.90 | 17084039 19081190 16996476 17043245 18987195 17434803 | |
| MESH:D010146 | Pain | Ibuprofen | 23.90 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 23.90 | 3291741 17627676 13679232 17440234 | |
| MESH:D010146 | Pain | montelukast | 23.90 | 15935457 | |
| MESH:D010146 | Pain | Phenytoin | 23.90 | 15215642 | |
| MESH:D010146 | Pain | Tretinoin | 23.90 | 16870215 | |
| MESH:D010146 | Pain | zileuton | 23.90 | 15935457 | |
| MESH:D010146 | Pain | zoledronic acid | 23.90 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 11.15 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 11.15 | 18702446 12538197 | |
| MESH:D010149 | Pain, Postoperative | rofecoxib | 11.15 | 18165598 16678543 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 28.13 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 28.13 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 28.13 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 28.13 | 17440100 19196508 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 28.13 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 28.13 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 28.13 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 28.13 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 28.13 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 28.13 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 28.13 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 28.13 | 15976015 | |
| MESH:D010195 | Pancreatitis | Antimony Sodium Gluconate | 13.16 | 7519887 | |
| MESH:D010195 | Pancreatitis | Cimetidine | 13.16 | 10484002 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 13.16 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 13.16 | 20035747 | |
| MESH:D010195 | Pancreatitis | Trinitrobenzenesulfonic Acid | 13.16 | 17698068 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.42 | 11578682 | |
| MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 11.63 | 7296757 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 11.63 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 11.63 | 12065085 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 11.63 | 18922899 12065085 8330346 18404319 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.89 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.35 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.65 | 17352947 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 8.19 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Homocysteine | 8.19 | 16275827 | |
| MESH:D010300 | Parkinson Disease | Iron | 8.19 | 16563566 16640825 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 8.19 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 8.19 | 11445065 12911755 11181820 15451049 16140633 15824117 11124998 16510128 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.12 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 2.93 | 12349958 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.35 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.88 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.80 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 4.19 | 11156591 | |
| MESH:D010518 | Periodontitis | Antimony Sodium Gluconate | 12.84 | 1325634 | |
| MESH:D010518 | Periodontitis | Indomethacin | 12.84 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 12.84 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 5.81 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.81 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 3.64 | 6392382 16905509 15371236 | |
| MESH:D010538 | Peritonitis | Isoflurane | 17.90 | 17414419 | |
| MESH:D010538 | Peritonitis | Ozone | 17.90 | 16369182 | |
| MESH:D010538 | Peritonitis | Thioglycolates | 17.90 | 15707874 19180231 19641140 11985352 19804847 18628355 16751407 | |
| MESH:D010538 | Peritonitis | zileuton | 17.90 | 17371808 | |
| MESH:D010538 | Peritonitis | Zymosan | 17.90 | 19088179 11985352 18557954 15979727 17826846 15259001 19641140 18977430 14761945 18760300 17371808 | |
| MESH:D020795 | Photophobia | Aspirin | 4.40 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 8.57 | 6228378 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 8.57 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.79 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 9.55 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 9.55 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.35 | 16977796 15687265 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.52 | 15087411 | |
| MESH:D010995 | Pleural Diseases | marker/mechanism | 10923243 | ||
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 8.27 | 10923243 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Serpentine | 8.27 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.42 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.42 | 17638057 | |
| MESH:D010998 | Pleurisy | Carrageenan | 5.39 | 19934399 | |
| MESH:D011014 | Pneumonia | Bleomycin | 20.95 | 18024389 16317386 17071938 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 20.95 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 20.95 | 11605937 12224865 | |
| MESH:D011014 | Pneumonia | Ozone | 20.95 | 18929643 18007984 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 20.95 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Hydrochloric Acid | 4.04 | 18573544 15607125 15970105 18497604 | |
| MESH:D011041 | Poisoning | Iron | 4.88 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 4.88 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Glycosylation End Products, Advanced | 7.11 | 17201808 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 7.11 | 17105841 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.84 | 9212184 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 6.73 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 6.73 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 5.26 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 5.26 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 2.62 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 3.30 | 16640825 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.80 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 21.05 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 21.05 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 21.05 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | mycophenolate mofetil | 21.05 | 18238994 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 21.05 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 21.05 | 11399792 11896295 11222880 11118676 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 6.41 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 6.41 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 11.78 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 11.78 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 11.78 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Berberine | 11.78 | 16505103 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 11.78 | 17914592 18487222 15638997 19011039 19240160 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 11.78 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 11.78 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 11.78 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 11.78 | 18226269 18156803 11398177 15129424 18769126 12497104 10851300 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 11.78 | 17136230 15846301 15046698 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 11.78 | 16868541 16729912 15749863 15897917 16888761 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 11.78 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 11.78 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 11.78 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 11.78 | 12376480 15682402 | |
| MESH:D011471 | Prostatic Neoplasms | parthenolide | 11.78 | 16921510 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 11.78 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 11.78 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 11.78 | 16220300 15731164 16536755 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 11.78 | 17636462 17675339 16731767 15767336 17718901 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 11.78 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 11.78 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 11.78 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 11.78 | 19103299 12438248 | |
| MESH:D011507 | Proteinuria | Arsenic | 19.79 | 21343184 | |
| MESH:D011507 | Proteinuria | Gentamicins | 19.79 | 15033597 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 19.79 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 19.79 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 19.79 | 16636307 | |
| MESH:D011507 | Proteinuria | valsartan | 19.79 | 18344623 17664856 12164870 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.65 | 16640825 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 8.67 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | Mustard Gas | 8.67 | 18058305 | |
| MESH:D011537 | Pruritus | zileuton | 8.67 | 19657356 17827870 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 4.18 | 1419762 8603615 12752131 | |
| MESH:D011565 | Psoriasis | Leukotriene B4 | 3.67 | 11006272 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.57 | 18769834 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.44 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.44 | 10548101 | |
| MESH:D001261 | Pulmonary Atelectasis | Hydrochloric Acid | 4.65 | 20597076 | |
| MESH:D011654 | Pulmonary Edema | Bleomycin | 10.60 | 15808516 | |
| MESH:D011654 | Pulmonary Edema | Hydrochloric Acid | 10.60 | 15090967 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 10.60 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.30 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 8.63 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 8.63 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | marker/mechanism | 17720292 16324872 | ||
| MESH:D011658 | Pulmonary Fibrosis | Amiodarone | 23.55 | 12490602 12832656 11597910 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 23.55 | 17975199 17365031 15814490 17322281 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Serpentine | 23.55 | 18569384 15511213 | |
| MESH:D011658 | Pulmonary Fibrosis | Bleomycin | 23.55 | 21435439 11554783 12624602 15322207 16115399 17177178 16314464 17241526 18162602 12574379 15541506 14609568 17434272 18008008 | |
| MESH:D011658 | Pulmonary Fibrosis | Enalapril | 23.55 | 17265423 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 23.55 | 17894541 17720292 17266442 10334151 17620002 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 23.55 | 17997886 16324872 | |
| MESH:D011658 | Pulmonary Fibrosis | tetrathiomolybdate | 23.55 | 15541506 12624602 | |
| MESH:D011658 | Pulmonary Fibrosis | troglitazone | 23.55 | 18162602 | |
| MESH:D011658 | Pulmonary Fibrosis | valsartan | 23.55 | 17241526 | |
| MESH:D011693 | Purpura | Raloxifene | 4.18 | 15770314 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 5.04 | 15830843 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 28.31 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 28.31 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 28.31 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Enalapril | 28.31 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 28.31 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 28.31 | 15728788 17132701 | |
| MESH:D051437 | Renal Insufficiency | Losartan | 28.31 | 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.21 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 17.33 | 19211983 18460982 | |
| MESH:D015427 | Reperfusion Injury | Leukotriene C4 | 17.33 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 17.33 | 15948865 16041266 16753835 15086910 14654979 15629865 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 17.33 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 17.33 | 15827377 16314181 16317513 17520802 17058453 | |
| MESH:D015427 | Reperfusion Injury | Superoxides | 17.33 | 18460982 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 17.33 | 9865762 15266012 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 23.33 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 23.33 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 23.33 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Hydrochloric Acid | 23.33 | 18549715 18339021 16129981 16784557 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 23.33 | 18339021 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 23.33 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 23.33 | 16129981 | |
| MESH:D012127 | Respiratory Distress Syndrome, Newborn | Vitamin A | 4.45 | 16877224 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 7.87 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | phthalic anhydride | 7.87 | 20219652 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 7.87 | 16940033 7692837 20219652 | |
| MESH:D012133 | Respiratory Paralysis | Hydrochloric Acid | 4.99 | 11510729 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 2.78 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.54 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Hydrochloric Acid | 6.75 | 20516732 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 6.75 | 18447907 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.42 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 8.54 | 3692021 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 8.54 | 18155124 18172121 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 8.54 | 16458197 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.91 | 18644591 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 3.41 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.14 | 11555667 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 2.83 | 16116481 16283617 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 21.90 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 21.90 | 12372130 | |
| MESH:D012220 | Rhinitis | montelukast | 21.90 | 20332717 | |
| MESH:D012220 | Rhinitis | Ovalbumin | 21.90 | 12689652 18298128 | |
| MESH:D012220 | Rhinitis | phthalic anhydride | 21.90 | 3681491 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 21.90 | 19050374 | |
| MESH:D012220 | Rhinitis | zileuton | 21.90 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 3.93 | 12617775 15015336 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 4.15 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.17 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.53 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.53 | 18313854 17203757 15625365 17710206 15675481 16767912 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 18.83 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 18.83 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 18.83 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 18.83 | 14601052 16326096 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 18.83 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.45 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.18 | 16862918 | |
| MESH:D012559 | Schizophrenia | marker/mechanism | 18486454 | ||
| MESH:D012559 | Schizophrenia | Copper | 3.40 | 16842975 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 3.40 | 16641680 | |
| MESH:D012559 | Schizophrenia | Homocysteine | 3.40 | 16641680 | |
| MESH:D012640 | Seizures | 3-xylene | 7.83 | 8907413 6431079 | |
| MESH:D012640 | Seizures | Acrylonitrile | 7.83 | 20127315 | |
| MESH:D012640 | Seizures | Clonidine | 7.83 | 10087439 | |
| MESH:D012640 | Seizures | Phenytoin | 7.83 | 10029267 3137016 9844417 11044598 16876388 3691417 19919933 15946322 | |
| MESH:D012640 | Seizures | Trinitrotoluene | 7.83 | 18551238 | |
| MESH:D018805 | Sepsis | Curcumin | 8.98 | 18389075 | |
| MESH:D018805 | Sepsis | Isoflurane | 8.98 | 17414419 | |
| MESH:D018805 | Sepsis | Zymosan | 8.98 | 11441115 | |
| MESH:D012772 | Shock, Septic | mangiferin | 3.91 | 15177305 | |
| OMIM:609620 | SHORT QT SYNDROME 1 | Amiodarone | 3.74 | 18724381 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 7.15 | 7327846 | |
| MESH:D012852 | Sinusitis | zileuton | 7.15 | 10665187 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 8.21 | 12269725 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Heparin | 8.21 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 10.54 | 19834688 17548696 16353154 18709164 6392382 17050553 16759981 17938729 16702368 17453740 15952646 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 10.54 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 10.54 | 17431481 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 10.54 | 12880345 15451306 16961503 | |
| MESH:D012871 | Skin Diseases | Vitamin A | 10.54 | 18709164 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 10.54 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 26.01 | 16251483 15504454 17029826 17976673 17050553 19538983 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 26.01 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 26.01 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 26.01 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 26.01 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 26.01 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 26.01 | 8985016 15837718 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 26.01 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 26.01 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 26.01 | 8985016 12065085 8330346 11807781 18404319 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 26.01 | 16467112 | |
| MESH:D020181 | Sleep Apnea, Obstructive | montelukast | 8.79 | 19118273 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 8.79 | 19118273 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Clonidine | 4.39 | 18280681 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.98 | 15464296 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 4.15 | 19075512 19050374 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.25 | 17203757 15625365 16767912 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 12.34 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 12.34 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 12.34 | 16709447 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.15 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | montelukast | 15.77 | 18059327 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 15.77 | 16503802 15862959 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 15.77 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 15.77 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | marker/mechanism | |||
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.66 | 12854658 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 3.91 | 12587719 | |
| MESH:D013163 | Splenomegaly | Antimony Sodium Gluconate | 8.58 | 9665985 | |
| MESH:D013163 | Splenomegaly | Trinitrotoluene | 8.58 | 15817613 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 3.84 | 20235791 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 5.97 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 5.97 | 16113693 15472012 10192188 17638125 18209964 16280098 17160473 18545984 17207306 15038085 10215738 16184426 10486359 | |
| MESH:D013274 | Stomach Neoplasms | Acrylonitrile | 20.71 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 20.71 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 20.71 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 20.71 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 20.71 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 20.71 | 17522103 18396642 15958060 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 20.71 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 20.71 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 20.71 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 20.71 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 20.71 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 20.71 | 16257854 15930296 18593901 | |
| MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 20.71 | 17575124 12958204 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 20.71 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | troglitazone | 20.71 | 15930296 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 20.71 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 18.69 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Amiodarone | 18.69 | 18087811 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 18.69 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 18.69 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Hydrochloric Acid | 18.69 | 17189318 15309881 16755016 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 18.69 | 18181030 16631530 12498302 10423059 16934674 18726076 11595431 17977527 18087811 12787963 12077510 16169175 17627676 17657623 12500499 17895592 11523592 17654042 18431645 18193104 12467913 18543354 18299717 17135157 18237397 17918041 14567935 11906479 16397915 1323529 18209962 10750652 11145282 16150113 11729361 10878458 15255614 16755016 15138204 11595415 16252198 15104355 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 18.69 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | montelukast | 18.69 | 17895592 | |
| MESH:D020521 | Stroke | Acrolein | 14.80 | 16269634 | |
| MESH:D020521 | Stroke | Aspirin | 14.80 | 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 14.80 | 16517955 | |
| MESH:D020521 | Stroke | Raloxifene | 14.80 | 16837676 | |
| MESH:D020521 | Stroke | Vitamin E | 14.80 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.25 | 16321402 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.68 | 16684133 16045194 | |
| MESH:D013398 | Sudden Infant Death | Iron | 8.87 | 16640825 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 8.87 | 12563064 | |
| MESH:D013610 | Tachycardia | Amiodarone | 3.00 | 11238279 | |
| MESH:D017180 | Tachycardia, Ventricular | Amiodarone | 2.91 | 19225199 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 4.36 | 17997062 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 3.63 | 15864552 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.36 | 17225452 15464296 | |
| MESH:D013921 | Thrombocytopenia | Heparin | 6.26 | 16893407 16651880 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 6.26 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.35 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 8.57 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 8.57 | 15669648 | |
| MESH:D013927 | Thrombosis | Heparin | 8.57 | 16893407 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 7.79 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 7.79 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Amiodarone | 7.55 | 19731979 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 7.55 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 16.91 | 6582329 3712494 7505956 6587162 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 16.91 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 16.91 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 16.91 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 16.91 | 18791128 14736730 11352223 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 16.91 | 7505956 3078959 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 16.91 | 16026305 17045167 | |
| MESH:D013971 | Thyrotoxicosis | Amiodarone | 3.53 | 19584973 18020914 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 9.20 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 9.20 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 5.85 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 5.85 | 16051514 | |
| MESH:D016171 | Torsades de Pointes | Amiodarone | 5.86 | 11989578 17467628 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 5.86 | 15213294 | |
| MESH:D014235 | Trichinellosis | mangiferin | 4.69 | 14669257 | |
| MESH:D014376 | Tuberculosis | marker/mechanism | |||
| MESH:D014376 | Tuberculosis | Iron | 4.79 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.79 | 16040207 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.55 | 10574470 17380554 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 29.03 | 8074119 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 29.03 | 15987713 19322015 19429237 17306315 18640142 17976673 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 29.03 | 20435036 12845720 11780464 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 29.03 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 29.03 | 12973940 15464296 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 29.03 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 29.03 | 17306315 16452187 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 29.03 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 29.03 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 29.03 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 29.03 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 29.03 | 11723127 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 29.03 | 17572228 16712894 8653321 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.92 | 18462866 | |
| MESH:D014581 | Urticaria | Acetaminophen | 10.97 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 10.97 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | montelukast | 10.97 | 10982225 | |
| MESH:D014581 | Urticaria | salmeterol | 10.97 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 16.92 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 16.92 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 16.92 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 16.92 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 16.92 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 9.30 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 9.30 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 16.63 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 16.63 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 16.63 | 16690809 15809267 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 16.63 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 16.63 | 17044934 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 3.25 | 16752155 | |
| MESH:D014605 | Uveitis | Dexamethasone | 12.81 | 1336536 | |
| MESH:D014605 | Uveitis | Endotoxins | 12.81 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 12.81 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 10.96 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 10.96 | 16513791 16002989 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 10.96 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 7.41 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.41 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.22 | 12125929 | |
| MESH:D014657 | Vasculitis | Heparin | 4.74 | 20337814 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 3.86 | 19057314 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.84 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.30 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 6.00 | 17678736 17638931 17334414 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 6.00 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | valsartan | 4.36 | 19027736 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 4.22 | 18776599 | |
| MESH:D014802 | Vitamin A Deficiency | Vitamin A | 4.00 | 16146918 16960172 16175781 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.77 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 7.04 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 7.04 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.18 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.88 | 15886252 | |
| MESH:D015431 | Weight Loss | Bleomycin | 8.52 | 12624602 | |
| MESH:D015431 | Weight Loss | tetrathiomolybdate | 8.52 | 12624602 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.76 | 16287080 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| KEGG:04062 | Chemokine signaling pathway |
| KEGG:04060 | Cytokine-cytokine receptor interaction |
| REACT:15380 | Diabetes pathways |
| KEGG:05144 | Malaria |
| KEGG:04621 | NOD-like receptor signaling pathway |
| KEGG:05323 | Rheumatoid arthritis |
| REACT:14797 | Signaling by GPCR |